JP2009513563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009513563A5 JP2009513563A5 JP2008525998A JP2008525998A JP2009513563A5 JP 2009513563 A5 JP2009513563 A5 JP 2009513563A5 JP 2008525998 A JP2008525998 A JP 2008525998A JP 2008525998 A JP2008525998 A JP 2008525998A JP 2009513563 A5 JP2009513563 A5 JP 2009513563A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxylic acid
- methyl
- methylthiazole
- amide
- thiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 25
- 125000003118 aryl group Chemical group 0.000 claims 24
- 125000000217 alkyl group Chemical group 0.000 claims 20
- 125000003710 aryl alkyl group Chemical group 0.000 claims 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 125000000623 heterocyclic group Chemical group 0.000 claims 20
- -1 —R 6 —OR 7 Chemical group 0.000 claims 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 19
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 16
- 201000010099 disease Diseases 0.000 claims 14
- 125000003342 alkenyl group Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 12
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 12
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 12
- 108010087894 Fatty acid desaturases Proteins 0.000 claims 10
- 102000016553 Stearoyl-CoA Desaturase Human genes 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 8
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 8
- 125000003367 polycyclic group Chemical group 0.000 claims 8
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 101000631826 Homo sapiens Stearoyl-CoA desaturase Proteins 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 102000055981 human SCD1 Human genes 0.000 claims 5
- 230000001404 mediated effect Effects 0.000 claims 5
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 4
- 208000008589 Obesity Diseases 0.000 claims 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 4
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000001246 bromo group Chemical group Br* 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 235000020824 obesity Nutrition 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000004952 trihaloalkoxy group Chemical group 0.000 claims 4
- 125000004385 trihaloalkyl group Chemical group 0.000 claims 4
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000003446 ligand Substances 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000004930 Fatty Liver Diseases 0.000 claims 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 2
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 2
- JPYQFYIEOUVJDU-UHFFFAOYSA-N beclamide Chemical compound ClCCC(=O)NCC1=CC=CC=C1 JPYQFYIEOUVJDU-UHFFFAOYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000010706 fatty liver disease Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 2
- GGNIKGLUPSHSBV-UHFFFAOYSA-N thiazole-5-carboxamide Chemical compound NC(=O)C1=CN=CS1 GGNIKGLUPSHSBV-UHFFFAOYSA-N 0.000 claims 2
- VLIQUKXIEPYSKY-UHFFFAOYSA-N 2-(adamantane-1-carbonylamino)-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound CC=1N=C(NC(=O)C23CC4CC(CC(C4)C2)C3)SC=1C(=O)NC1=CC=CC=C1 VLIQUKXIEPYSKY-UHFFFAOYSA-N 0.000 claims 1
- SPDBHWFZMQBCCK-UHFFFAOYSA-N 2-(adamantane-1-carbonylamino)-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C34CC5CC(CC(C5)C3)C4)S2)C)=C1 SPDBHWFZMQBCCK-UHFFFAOYSA-N 0.000 claims 1
- HKFDNWAYIYAEPK-UHFFFAOYSA-N 2-(adamantane-1-carbonylamino)-n-(4-bromophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound CC=1N=C(NC(=O)C23CC4CC(CC(C4)C2)C3)SC=1C(=O)NC1=CC=C(Br)C=C1 HKFDNWAYIYAEPK-UHFFFAOYSA-N 0.000 claims 1
- GGZFXQNWOMNLMF-UHFFFAOYSA-N 2-(adamantane-1-carbonylamino)-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C23CC4CC(CC(C4)C2)C3)S1 GGZFXQNWOMNLMF-UHFFFAOYSA-N 0.000 claims 1
- IDAICGYHWIDEND-UHFFFAOYSA-N 2-(adamantane-1-carbonylamino)-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound CC=1N=C(NC(=O)C23CC4CC(CC(C4)C2)C3)SC=1C(=O)NC1CCCCC1 IDAICGYHWIDEND-UHFFFAOYSA-N 0.000 claims 1
- KLRMOJAEJFTUKN-UHFFFAOYSA-N 2-(cyclohexanecarbonylamino)-n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1CCCCC1 KLRMOJAEJFTUKN-UHFFFAOYSA-N 0.000 claims 1
- FGHTZCGRZARSTI-UHFFFAOYSA-N 2-(cyclohexanecarbonylamino)-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1CCCCC1 FGHTZCGRZARSTI-UHFFFAOYSA-N 0.000 claims 1
- WIVAFIPIRYDUPG-UHFFFAOYSA-N 2-(cyclohexanecarbonylamino)-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C2CCCCC2)S1 WIVAFIPIRYDUPG-UHFFFAOYSA-N 0.000 claims 1
- VADCVJMOSZEHJD-UHFFFAOYSA-N 2-(cyclopropanecarbonylamino)-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1CC1 VADCVJMOSZEHJD-UHFFFAOYSA-N 0.000 claims 1
- CKJSARLXLUFZSU-UHFFFAOYSA-N 2-(cyclopropanecarbonylamino)-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CC1 CKJSARLXLUFZSU-UHFFFAOYSA-N 0.000 claims 1
- NVTSHLRAUHCNOQ-UHFFFAOYSA-N 2-(cyclopropanecarbonylamino)-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1CC1 NVTSHLRAUHCNOQ-UHFFFAOYSA-N 0.000 claims 1
- GAPNCDYWAMKXRL-UHFFFAOYSA-N 2-(cyclopropanecarbonylamino)-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C2CC2)S1 GAPNCDYWAMKXRL-UHFFFAOYSA-N 0.000 claims 1
- ODSGGDGRAYREDJ-UHFFFAOYSA-N 2-(furan-2-carbonylamino)-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=CO1 ODSGGDGRAYREDJ-UHFFFAOYSA-N 0.000 claims 1
- ACJDFTFXUVWTPP-UHFFFAOYSA-N 2-(furan-2-carbonylamino)-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CO1 ACJDFTFXUVWTPP-UHFFFAOYSA-N 0.000 claims 1
- VDNQGOYRMZFXMJ-UHFFFAOYSA-N 2-(furan-2-carbonylamino)-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3OC=CC=3)S2)C)=C1 VDNQGOYRMZFXMJ-UHFFFAOYSA-N 0.000 claims 1
- LJOPCFKGLLSAEH-UHFFFAOYSA-N 2-(furan-2-carbonylamino)-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2OC=CC=2)S1 LJOPCFKGLLSAEH-UHFFFAOYSA-N 0.000 claims 1
- XPRILLPYKLYJEF-UHFFFAOYSA-N 2-[(2,6-difluorobenzoyl)amino]-n,n,4-trimethyl-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)N(C)C)SC(NC(=O)C=2C(=CC=CC=2F)F)=N1 XPRILLPYKLYJEF-UHFFFAOYSA-N 0.000 claims 1
- WAEUCPJLEKTDNQ-UHFFFAOYSA-N 2-[(2-fluorobenzoyl)amino]-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=CC=C1F WAEUCPJLEKTDNQ-UHFFFAOYSA-N 0.000 claims 1
- LGAGLGKDTZLBFL-UHFFFAOYSA-N 2-[(2-fluorobenzoyl)amino]-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C(=CC=CC=2)F)S1 LGAGLGKDTZLBFL-UHFFFAOYSA-N 0.000 claims 1
- JUPUHXSAEJUNCO-UHFFFAOYSA-N 2-[(3,4-dimethoxybenzoyl)amino]-n,n,4-trimethyl-1,3-thiazole-5-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)N(C)C)S1 JUPUHXSAEJUNCO-UHFFFAOYSA-N 0.000 claims 1
- GXRWTEXBAFYUTG-UHFFFAOYSA-N 2-[(3-chlorobenzoyl)amino]-4-methyl-n-pyridin-3-yl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=NC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(Cl)=C1 GXRWTEXBAFYUTG-UHFFFAOYSA-N 0.000 claims 1
- QRBLCSFOPHGZTG-UHFFFAOYSA-N 2-[(3-chlorobenzoyl)amino]-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1=CC=CC(Cl)=C1 QRBLCSFOPHGZTG-UHFFFAOYSA-N 0.000 claims 1
- JIVOUFQCAKZGIZ-UHFFFAOYSA-N 2-[(3-fluorobenzoyl)amino]-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 JIVOUFQCAKZGIZ-UHFFFAOYSA-N 0.000 claims 1
- UGPLMWZNVWBFMN-UHFFFAOYSA-N 2-[(3-fluorobenzoyl)amino]-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=C(F)C=CC=3)S2)C)=C1 UGPLMWZNVWBFMN-UHFFFAOYSA-N 0.000 claims 1
- HWPUVTPZRTVOCS-UHFFFAOYSA-N 2-[(3-methoxybenzoyl)amino]-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=C(OC)C=CC=2)S1 HWPUVTPZRTVOCS-UHFFFAOYSA-N 0.000 claims 1
- ACCZUFUAAWJOFF-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 ACCZUFUAAWJOFF-UHFFFAOYSA-N 0.000 claims 1
- NYNGPHCKHRMRTO-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NN=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC(Br)=CC=2)S1 NYNGPHCKHRMRTO-UHFFFAOYSA-N 0.000 claims 1
- MZDNHDMQDBCUSC-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 MZDNHDMQDBCUSC-UHFFFAOYSA-N 0.000 claims 1
- AGPOHGLIDBVZFV-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 AGPOHGLIDBVZFV-UHFFFAOYSA-N 0.000 claims 1
- BPKOSGSKZHLOGF-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 BPKOSGSKZHLOGF-UHFFFAOYSA-N 0.000 claims 1
- SJWWHZUQPNCUFF-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(2-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 SJWWHZUQPNCUFF-UHFFFAOYSA-N 0.000 claims 1
- YAYCOAKURJYPMR-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(3-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 YAYCOAKURJYPMR-UHFFFAOYSA-N 0.000 claims 1
- SXPKOFURMHQDAA-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=CC(Br)=CC=3)S2)C)=C1 SXPKOFURMHQDAA-UHFFFAOYSA-N 0.000 claims 1
- UCNCQVUBGAYCQD-UHFFFAOYSA-N 2-[(4-bromobenzoyl)amino]-n-(4-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 UCNCQVUBGAYCQD-UHFFFAOYSA-N 0.000 claims 1
- RJSHOQINULMKFZ-UHFFFAOYSA-N 2-[(4-chlorobenzoyl)amino]-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1=CC=C(Cl)C=C1 RJSHOQINULMKFZ-UHFFFAOYSA-N 0.000 claims 1
- ZFUNSSFJDKYBGQ-UHFFFAOYSA-N 2-[(4-fluorobenzoyl)amino]-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 ZFUNSSFJDKYBGQ-UHFFFAOYSA-N 0.000 claims 1
- HKDQLLSSZBTEHN-UHFFFAOYSA-N 2-[(4-fluorobenzoyl)amino]-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 HKDQLLSSZBTEHN-UHFFFAOYSA-N 0.000 claims 1
- VKIUTSMYUNUFBY-UHFFFAOYSA-N 2-[(4-fluorobenzoyl)amino]-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=CC(F)=CC=3)S2)C)=C1 VKIUTSMYUNUFBY-UHFFFAOYSA-N 0.000 claims 1
- IGXFSZXDMNSWLF-UHFFFAOYSA-N 2-[(4-fluorobenzoyl)amino]-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC(F)=CC=2)S1 IGXFSZXDMNSWLF-UHFFFAOYSA-N 0.000 claims 1
- NXLIWBXLXGCDTL-UHFFFAOYSA-N 2-[(4-methoxybenzoyl)amino]-4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)NC=2SC(C)=NN=2)S1 NXLIWBXLXGCDTL-UHFFFAOYSA-N 0.000 claims 1
- CHMHSZJFHVIZAS-UHFFFAOYSA-N 2-[(4-methoxybenzoyl)amino]-4-methyl-n-pyridin-3-yl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)NC=2C=NC=CC=2)S1 CHMHSZJFHVIZAS-UHFFFAOYSA-N 0.000 claims 1
- UGJUYPFNXBFDBO-UHFFFAOYSA-N 2-[(4-methoxybenzoyl)amino]-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)NC=2C=C(OC)C=CC=2)S1 UGJUYPFNXBFDBO-UHFFFAOYSA-N 0.000 claims 1
- JKWYMYLDQJWLQW-UHFFFAOYSA-N 2-[(4-tert-butylbenzoyl)amino]-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 JKWYMYLDQJWLQW-UHFFFAOYSA-N 0.000 claims 1
- SVBKEHJREWUSEM-UHFFFAOYSA-N 2-[(4-tert-butylbenzoyl)amino]-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 SVBKEHJREWUSEM-UHFFFAOYSA-N 0.000 claims 1
- AJEQAEVMCLAXPQ-UHFFFAOYSA-N 2-[(4-tert-butylbenzoyl)amino]-n-(2-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 AJEQAEVMCLAXPQ-UHFFFAOYSA-N 0.000 claims 1
- LAIAKLIMDXIAEY-UHFFFAOYSA-N 2-[(4-tert-butylbenzoyl)amino]-n-(3-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 LAIAKLIMDXIAEY-UHFFFAOYSA-N 0.000 claims 1
- UAXLRNUJHHPGIN-UHFFFAOYSA-N 2-[(4-tert-butylbenzoyl)amino]-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 UAXLRNUJHHPGIN-UHFFFAOYSA-N 0.000 claims 1
- RNYKGCOHFYKIBQ-UHFFFAOYSA-N 2-[(5-chloro-3-methyl-1-phenylpyrazole-4-carbonyl)amino]-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C(=C1Cl)C(C)=NN1C1=CC=CC=C1 RNYKGCOHFYKIBQ-UHFFFAOYSA-N 0.000 claims 1
- KYMUWSWURYAZFD-UHFFFAOYSA-N 2-[(5-chloro-3-methyl-1-phenylpyrazole-4-carbonyl)amino]-n-(2-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C(=C1Cl)C(C)=NN1C1=CC=CC=C1 KYMUWSWURYAZFD-UHFFFAOYSA-N 0.000 claims 1
- DQWLXLOXHAEJNG-UHFFFAOYSA-N 2-[(5-chloro-3-methyl-1-phenylpyrazole-4-carbonyl)amino]-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C(=C1Cl)C(C)=NN1C1=CC=CC=C1 DQWLXLOXHAEJNG-UHFFFAOYSA-N 0.000 claims 1
- RLCPSSDWNZUSMG-UHFFFAOYSA-N 2-[(6,8-dimethyl-2-pyridin-4-ylquinoline-4-carbonyl)amino]-n,n,4-trimethyl-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)N(C)C)SC(NC(=O)C=2C3=CC(C)=CC(C)=C3N=C(C=2)C=2C=CN=CC=2)=N1 RLCPSSDWNZUSMG-UHFFFAOYSA-N 0.000 claims 1
- XHOMEIFWDUYICG-UHFFFAOYSA-N 2-[2-(4-chloro-2-methylphenoxy)propanoylamino]-n,n,4-trimethyl-1,3-thiazole-5-carboxamide Chemical compound N=1C(C)=C(C(=O)N(C)C)SC=1NC(=O)C(C)OC1=CC=C(Cl)C=C1C XHOMEIFWDUYICG-UHFFFAOYSA-N 0.000 claims 1
- VDSHAVJUQXMWFU-UHFFFAOYSA-N 2-[2-[[5-(benzylcarbamoyl)-4-methyl-1,3-thiazol-2-yl]amino]-2-oxoethyl]benzoic acid Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CC1=CC=CC=C1C(O)=O VDSHAVJUQXMWFU-UHFFFAOYSA-N 0.000 claims 1
- PFYVVYXJNXUVQZ-UHFFFAOYSA-N 2-[benzoyl(methyl)amino]-n-benzyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound N=1C(C)=C(C(=O)NCC=2C=CC=CC=2)SC=1N(C)C(=O)C1=CC=CC=C1 PFYVVYXJNXUVQZ-UHFFFAOYSA-N 0.000 claims 1
- LJZBIQGZYUIIEV-UHFFFAOYSA-N 2-acetamido-4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C)=NC(C)=C1C(=O)NC1=NN=C(C)S1 LJZBIQGZYUIIEV-UHFFFAOYSA-N 0.000 claims 1
- SGFWBABEKCYIGO-UHFFFAOYSA-N 2-acetamido-n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C)=NC(C)=C1C(=O)NC1=CC=C(CCC2)C2=C1 SGFWBABEKCYIGO-UHFFFAOYSA-N 0.000 claims 1
- VEIJNDLCQOKLDZ-UHFFFAOYSA-N 2-acetamido-n-(3-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C)=NC(C)=C1C(=O)NC1=CC=CC(Cl)=C1 VEIJNDLCQOKLDZ-UHFFFAOYSA-N 0.000 claims 1
- UGOCCIBPEYBADQ-UHFFFAOYSA-N 2-acetamido-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(C)=O)S2)C)=C1 UGOCCIBPEYBADQ-UHFFFAOYSA-N 0.000 claims 1
- MQGBDJYBSZSYFX-UHFFFAOYSA-N 2-acetamido-n-(4-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C)=NC(C)=C1C(=O)NC1=CC=C(Cl)C=C1 MQGBDJYBSZSYFX-UHFFFAOYSA-N 0.000 claims 1
- XUUDHSZVYVVFPZ-UHFFFAOYSA-N 2-acetamido-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(C)=O)S1 XUUDHSZVYVVFPZ-UHFFFAOYSA-N 0.000 claims 1
- KEEACXQCXMUMTB-UHFFFAOYSA-N 2-acetamido-n-cyclohexyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C)=NC(C)=C1C(=O)NC1CCCCC1 KEEACXQCXMUMTB-UHFFFAOYSA-N 0.000 claims 1
- FNMXJKQEMNOPAU-UHFFFAOYSA-N 2-benzamido-4-methyl-n-(1-phenylpropyl)-1,3-thiazole-5-carboxamide Chemical compound C=1C=CC=CC=1C(CC)NC(=O)C(=C(N=1)C)SC=1NC(=O)C1=CC=CC=C1 FNMXJKQEMNOPAU-UHFFFAOYSA-N 0.000 claims 1
- LBXUICVUHMBQLF-UHFFFAOYSA-N 2-benzamido-4-methyl-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=CC=C1 LBXUICVUHMBQLF-UHFFFAOYSA-N 0.000 claims 1
- NIMMHYIFQNMFRO-UHFFFAOYSA-N 2-benzamido-4-methyl-n-(2-phenylethyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 NIMMHYIFQNMFRO-UHFFFAOYSA-N 0.000 claims 1
- UUDDSWLXPIWXKB-UHFFFAOYSA-N 2-benzamido-4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NN=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC=CC=2)S1 UUDDSWLXPIWXKB-UHFFFAOYSA-N 0.000 claims 1
- YQJNHVYJXUIVBZ-UHFFFAOYSA-N 2-benzamido-4-methyl-n-[[2-(trifluoromethyl)phenyl]methyl]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C(=CC=CC=2)C(F)(F)F)=C(C)N=C1NC(=O)C1=CC=CC=C1 YQJNHVYJXUIVBZ-UHFFFAOYSA-N 0.000 claims 1
- VUPOVEVEJLSSRH-UHFFFAOYSA-N 2-benzamido-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 VUPOVEVEJLSSRH-UHFFFAOYSA-N 0.000 claims 1
- IDVRFGPDEOQVIU-UHFFFAOYSA-N 2-benzamido-n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 IDVRFGPDEOQVIU-UHFFFAOYSA-N 0.000 claims 1
- WLNUQXBQFYIIOZ-UHFFFAOYSA-N 2-benzamido-n-(3-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 WLNUQXBQFYIIOZ-UHFFFAOYSA-N 0.000 claims 1
- SDHHVQGQNIGRAZ-UHFFFAOYSA-N 2-benzamido-n-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=C1 SDHHVQGQNIGRAZ-UHFFFAOYSA-N 0.000 claims 1
- YRVZINYAXXQFGT-UHFFFAOYSA-N 2-benzamido-n-(4-bromophenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 YRVZINYAXXQFGT-UHFFFAOYSA-N 0.000 claims 1
- VZSBSCGTTDWMCG-UHFFFAOYSA-N 2-benzamido-n-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC=CC=2)S1 VZSBSCGTTDWMCG-UHFFFAOYSA-N 0.000 claims 1
- MQDJESQGTPXBRS-UHFFFAOYSA-N 2-benzamido-n-(cyclopropylmethyl)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC2CC2)=C(C)N=C1NC(=O)C1=CC=CC=C1 MQDJESQGTPXBRS-UHFFFAOYSA-N 0.000 claims 1
- LXINDBBBCIXKHW-UHFFFAOYSA-N 2-benzamido-n-[(2-chlorophenyl)methyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=CC=C1 LXINDBBBCIXKHW-UHFFFAOYSA-N 0.000 claims 1
- NYJBAHPZOZMGIH-UHFFFAOYSA-N 2-benzamido-n-[(2-fluorophenyl)methyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C(=CC=CC=2)F)=C(C)N=C1NC(=O)C1=CC=CC=C1 NYJBAHPZOZMGIH-UHFFFAOYSA-N 0.000 claims 1
- SPOWAQLBSMWHDX-UHFFFAOYSA-N 2-benzamido-n-[(3-chlorophenyl)methyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 SPOWAQLBSMWHDX-UHFFFAOYSA-N 0.000 claims 1
- NOVJLADTBBJFES-UHFFFAOYSA-N 2-benzamido-n-[(3-fluorophenyl)methyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=C(F)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 NOVJLADTBBJFES-UHFFFAOYSA-N 0.000 claims 1
- IFZFSODWWVZEHL-UHFFFAOYSA-N 2-benzamido-n-[(4-fluorophenyl)methyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC(F)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 IFZFSODWWVZEHL-UHFFFAOYSA-N 0.000 claims 1
- MZEDARPIUXMJLY-UHFFFAOYSA-N 2-benzamido-n-benzyl-1,3-thiazole-5-carboxamide Chemical compound C=1N=C(NC(=O)C=2C=CC=CC=2)SC=1C(=O)NCC1=CC=CC=C1 MZEDARPIUXMJLY-UHFFFAOYSA-N 0.000 claims 1
- QSVYYBDOIGJYEY-UHFFFAOYSA-N 2-benzamido-n-benzyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C(F)(F)F)N=C1NC(=O)C1=CC=CC=C1 QSVYYBDOIGJYEY-UHFFFAOYSA-N 0.000 claims 1
- BOYAYWPPGDHJKG-UHFFFAOYSA-N 2-benzamido-n-benzyl-4-chloro-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(Cl)N=C1NC(=O)C1=CC=CC=C1 BOYAYWPPGDHJKG-UHFFFAOYSA-N 0.000 claims 1
- UIQYOIVHVXDSBZ-UHFFFAOYSA-N 2-benzamido-n-benzyl-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 UIQYOIVHVXDSBZ-UHFFFAOYSA-N 0.000 claims 1
- WTBUGQFGPAZWCK-UHFFFAOYSA-N 2-benzamido-n-benzyl-4-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=C1C(=O)NCC1=CC=CC=C1 WTBUGQFGPAZWCK-UHFFFAOYSA-N 0.000 claims 1
- QPUXBXCQOUTLDI-UHFFFAOYSA-N 2-chloro-n-(4-oxo-5,6,7,8-tetrahydro-[1,3]thiazolo[5,4-c]azepin-2-yl)benzamide Chemical compound ClC1=CC=CC=C1C(=O)NC(S1)=NC2=C1C(=O)NCCC2 QPUXBXCQOUTLDI-UHFFFAOYSA-N 0.000 claims 1
- GYGHPAULYFSBFX-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-(phenylcarbamoyl)-1,3-thiazol-2-yl]-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 GYGHPAULYFSBFX-UHFFFAOYSA-N 0.000 claims 1
- XMHOHBGGLZRISF-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)N2CCCCC2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 XMHOHBGGLZRISF-UHFFFAOYSA-N 0.000 claims 1
- HAWYVSHADQVHNN-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-[(2-methylphenyl)carbamoyl]-1,3-thiazol-2-yl]-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 HAWYVSHADQVHNN-UHFFFAOYSA-N 0.000 claims 1
- QTYHJZHDQDVSTK-UHFFFAOYSA-N 3-methyl-n-[4-methyl-5-[(5-methyl-1,3,4-thiadiazol-2-yl)carbamoyl]-1,3-thiazol-2-yl]-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C)=NN=C1NC(=O)C1=C(C)N=C(NC(=O)C=2SC=3N(C=4C=CC=CC=4)N=C(C)C=3C=2)S1 QTYHJZHDQDVSTK-UHFFFAOYSA-N 0.000 claims 1
- LCBSRHRUJUCUEM-UHFFFAOYSA-N 4-amino-2-benzamido-n-benzyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(N)N=C1NC(=O)C1=CC=CC=C1 LCBSRHRUJUCUEM-UHFFFAOYSA-N 0.000 claims 1
- BGTIIRYHWGADFD-UHFFFAOYSA-N 4-benzylbenzamide Chemical compound C1=CC(C(=O)N)=CC=C1CC1=CC=CC=C1 BGTIIRYHWGADFD-UHFFFAOYSA-N 0.000 claims 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 claims 1
- ZNARUTZFCQMHIA-UHFFFAOYSA-N 4-methyl-2-(3-phenylprop-2-enoylamino)-n-pyridin-3-yl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=NC=CC=2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 ZNARUTZFCQMHIA-UHFFFAOYSA-N 0.000 claims 1
- WEQYSAYUKCUIJQ-UHFFFAOYSA-N 4-methyl-2-[(1-oxo-2-phenoxyethyl)amino]-N-phenyl-5-thiazolecarboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 WEQYSAYUKCUIJQ-UHFFFAOYSA-N 0.000 claims 1
- JRNBTOOUBSVTAJ-UHFFFAOYSA-N 4-methyl-2-[(4-methylbenzoyl)amino]-n-(2-methylphenyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 JRNBTOOUBSVTAJ-UHFFFAOYSA-N 0.000 claims 1
- BBPCOSNTNQWTJY-UHFFFAOYSA-N 4-methyl-2-[(4-methylbenzoyl)amino]-n-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NN=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC(C)=CC=2)S1 BBPCOSNTNQWTJY-UHFFFAOYSA-N 0.000 claims 1
- FNFNWIVUIOBEMO-UHFFFAOYSA-N 4-methyl-2-[(4-methylbenzoyl)amino]-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 FNFNWIVUIOBEMO-UHFFFAOYSA-N 0.000 claims 1
- QIFWRSGFHRTAEN-UHFFFAOYSA-N 4-methyl-2-[(4-methylbenzoyl)amino]-n-pyridin-3-yl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=NC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 QIFWRSGFHRTAEN-UHFFFAOYSA-N 0.000 claims 1
- MCVRIWVHWHFAEH-UHFFFAOYSA-N 4-methyl-2-[(4-nitrobenzoyl)amino]-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 MCVRIWVHWHFAEH-UHFFFAOYSA-N 0.000 claims 1
- NPIIWHKEXGNGDR-UHFFFAOYSA-N 4-methyl-n-(2-methylphenyl)-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 NPIIWHKEXGNGDR-UHFFFAOYSA-N 0.000 claims 1
- MEUVZJJYVRRHKZ-UHFFFAOYSA-N 4-methyl-n-(2-methylphenyl)-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=CC=C1C MEUVZJJYVRRHKZ-UHFFFAOYSA-N 0.000 claims 1
- ZRYNVDXPYONASQ-UHFFFAOYSA-N 4-methyl-n-(2-methylphenyl)-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)COC1=CC=CC=C1 ZRYNVDXPYONASQ-UHFFFAOYSA-N 0.000 claims 1
- BWHYFBKKYRVSCD-UHFFFAOYSA-N 4-methyl-n-(2-methylphenyl)-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C(=CC=CC=2)C)=C1 BWHYFBKKYRVSCD-UHFFFAOYSA-N 0.000 claims 1
- QWGAFDMNTOIMJW-UHFFFAOYSA-N 4-methyl-n-(2-methylphenyl)-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)C)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 QWGAFDMNTOIMJW-UHFFFAOYSA-N 0.000 claims 1
- RMOZDIBMQMEMPB-UHFFFAOYSA-N 4-methyl-n-(2-phenylethyl)-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1 RMOZDIBMQMEMPB-UHFFFAOYSA-N 0.000 claims 1
- XGVXJGCIJIMEJL-UHFFFAOYSA-N 4-methyl-n-(3-phenylpropyl)-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCCCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1 XGVXJGCIJIMEJL-UHFFFAOYSA-N 0.000 claims 1
- DQUOMBYOSLFDFK-UHFFFAOYSA-N 4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-2-(thiophene-2-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NN=C1NC(=O)C1=C(C)N=C(NC(=O)C=2SC=CC=2)S1 DQUOMBYOSLFDFK-UHFFFAOYSA-N 0.000 claims 1
- TYTZMVGCVVRVED-UHFFFAOYSA-N 4-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2SC(C)=NN=2)=C1 TYTZMVGCVVRVED-UHFFFAOYSA-N 0.000 claims 1
- ZNAACUGAUHRQTK-UHFFFAOYSA-N 4-methyl-n-phenyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=CC=CC=2)=C1 ZNAACUGAUHRQTK-UHFFFAOYSA-N 0.000 claims 1
- OCETYEQWKZTRCO-OUKQBFOZSA-N 4-methyl-n-phenyl-2-[[(e)-3-phenylprop-2-enoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC=CC=2)=C(C)N=C1NC(=O)\C=C\C1=CC=CC=C1 OCETYEQWKZTRCO-OUKQBFOZSA-N 0.000 claims 1
- MSSPQIAUJWRIKA-UHFFFAOYSA-N 5-tert-butyl-n-(7,7-dimethyl-4-oxo-6,8-dihydro-5h-[1,3]thiazolo[5,4-c]azepin-2-yl)-2-methylpyrazole-3-carboxamide Chemical compound CN1N=C(C(C)(C)C)C=C1C(=O)NC(S1)=NC2=C1C(=O)NCC(C)(C)C2 MSSPQIAUJWRIKA-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- 229940123208 Biguanide Drugs 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 229920001268 Cholestyramine Polymers 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 208000002249 Diabetes Complications Diseases 0.000 claims 1
- 206010012655 Diabetic complications Diseases 0.000 claims 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 201000001431 Hyperuricemia Diseases 0.000 claims 1
- 229940122199 Insulin secretagogue Drugs 0.000 claims 1
- 229940122355 Insulin sensitizer Drugs 0.000 claims 1
- 206010023330 Keloid scar Diseases 0.000 claims 1
- 102000016267 Leptin Human genes 0.000 claims 1
- 108010092277 Leptin Proteins 0.000 claims 1
- DDUKEPBTDBKOOD-UHFFFAOYSA-N N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1CC1 DDUKEPBTDBKOOD-UHFFFAOYSA-N 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 102000018692 Sulfonylurea Receptors Human genes 0.000 claims 1
- 108010091821 Sulfonylurea Receptors Proteins 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 150000004283 biguanides Chemical class 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- JNWSTEWIXVHYNR-UHFFFAOYSA-N ethyl 2-[(2-benzamido-4-methyl-1,3-thiazole-5-carbonyl)amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=CC=CC=2)=N1 JNWSTEWIXVHYNR-UHFFFAOYSA-N 0.000 claims 1
- IHFWDNOFDRSICE-UHFFFAOYSA-N ethyl 2-[[2-[(2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C(=CC=CC=2)F)=N1 IHFWDNOFDRSICE-UHFFFAOYSA-N 0.000 claims 1
- DVPBEXPNYNWGRK-UHFFFAOYSA-N ethyl 2-[[2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=C(F)C=CC=2)=N1 DVPBEXPNYNWGRK-UHFFFAOYSA-N 0.000 claims 1
- KVUMEZRFGIOHOQ-UHFFFAOYSA-N ethyl 2-[[2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=C(OC)C=CC=2)=N1 KVUMEZRFGIOHOQ-UHFFFAOYSA-N 0.000 claims 1
- FSNMMMLVOKEPKN-UHFFFAOYSA-N ethyl 2-[[2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=CC(F)=CC=2)=N1 FSNMMMLVOKEPKN-UHFFFAOYSA-N 0.000 claims 1
- DXHAMFRIDXFDMH-UHFFFAOYSA-N ethyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=CC(OC)=CC=2)=N1 DXHAMFRIDXFDMH-UHFFFAOYSA-N 0.000 claims 1
- RYNURAKYSLCLAP-UHFFFAOYSA-N ethyl 2-[[4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=CC=2C=CC=CC=2)=N1 RYNURAKYSLCLAP-UHFFFAOYSA-N 0.000 claims 1
- HUCZWZCBANVUJV-UHFFFAOYSA-N ethyl 2-[[4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carbonyl]amino]acetate Chemical compound CC1=C(C(=O)NCC(=O)OCC)SC(NC(=O)C=2C=C(OC)C(OC)=C(OC)C=2)=N1 HUCZWZCBANVUJV-UHFFFAOYSA-N 0.000 claims 1
- 229940125753 fibrate Drugs 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003914 insulin secretion Effects 0.000 claims 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 1
- 229940039781 leptin Drugs 0.000 claims 1
- 230000003278 mimic effect Effects 0.000 claims 1
- YHRYAJGCLLMPIT-UHFFFAOYSA-N n,n,4-trimethyl-2-(2-phenylpropanoylamino)-1,3-thiazole-5-carboxamide Chemical compound C=1C=CC=CC=1C(C)C(=O)NC1=NC(C)=C(C(=O)N(C)C)S1 YHRYAJGCLLMPIT-UHFFFAOYSA-N 0.000 claims 1
- RPACRJMCMQBJNM-UHFFFAOYSA-N n,n,4-trimethyl-2-[(3-methyl-1-benzofuran-2-carbonyl)amino]-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)N(C)C)SC(NC(=O)C2=C(C3=CC=CC=C3O2)C)=N1 RPACRJMCMQBJNM-UHFFFAOYSA-N 0.000 claims 1
- WERDKOLGMDDCII-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C3OCCOC3=CC=2)=C1 WERDKOLGMDDCII-UHFFFAOYSA-N 0.000 claims 1
- SSWQHINERIDLCO-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 SSWQHINERIDLCO-UHFFFAOYSA-N 0.000 claims 1
- WOOSOAWTEFKYEG-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(4-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)NC=2C=C3OCCOC3=CC=2)S1 WOOSOAWTEFKYEG-UHFFFAOYSA-N 0.000 claims 1
- BVLMJOOMMVPFRN-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 BVLMJOOMMVPFRN-UHFFFAOYSA-N 0.000 claims 1
- JNQGZPQSDZGYAR-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-(thiophene-2-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CS1 JNQGZPQSDZGYAR-UHFFFAOYSA-N 0.000 claims 1
- GGKWQNRHWZWITE-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 GGKWQNRHWZWITE-UHFFFAOYSA-N 0.000 claims 1
- IHJSGJVXUYXNEB-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C3OCCOC3=CC=2)=C1 IHJSGJVXUYXNEB-UHFFFAOYSA-N 0.000 claims 1
- NIWKYZVEUVSUKR-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 NIWKYZVEUVSUKR-UHFFFAOYSA-N 0.000 claims 1
- NGYSWEVVCLHVQA-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 NGYSWEVVCLHVQA-UHFFFAOYSA-N 0.000 claims 1
- RXLIMWSBYKRKJS-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 RXLIMWSBYKRKJS-UHFFFAOYSA-N 0.000 claims 1
- CVYHWPKGHIBZAS-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 CVYHWPKGHIBZAS-UHFFFAOYSA-N 0.000 claims 1
- YRRICHXYUJMRRD-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C3CCCC3=CC=2)=C1 YRRICHXYUJMRRD-UHFFFAOYSA-N 0.000 claims 1
- AOVUGFYXLDXERK-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 AOVUGFYXLDXERK-UHFFFAOYSA-N 0.000 claims 1
- HRWACIOWLRMXPM-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 HRWACIOWLRMXPM-UHFFFAOYSA-N 0.000 claims 1
- DZTPAZMKNYLIMX-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=C(CCC2)C2=C1 DZTPAZMKNYLIMX-UHFFFAOYSA-N 0.000 claims 1
- KXLOICIBKDRVES-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(2-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1C KXLOICIBKDRVES-UHFFFAOYSA-N 0.000 claims 1
- ISFJREQYTHGOGT-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 ISFJREQYTHGOGT-UHFFFAOYSA-N 0.000 claims 1
- PSGBEOHUSHUPRD-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C3CCCC3=CC=2)=C1 PSGBEOHUSHUPRD-UHFFFAOYSA-N 0.000 claims 1
- ZQRSSLZCVSRHHO-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 ZQRSSLZCVSRHHO-UHFFFAOYSA-N 0.000 claims 1
- ATKBHPCMMTXFNF-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 ATKBHPCMMTXFNF-UHFFFAOYSA-N 0.000 claims 1
- UEOILAQCWQYBDT-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-5-yl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 UEOILAQCWQYBDT-UHFFFAOYSA-N 0.000 claims 1
- GCBOYDXMQQGXPF-UHFFFAOYSA-N n-(2-chlorophenyl)-2-(cyclohexanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1CCCCC1 GCBOYDXMQQGXPF-UHFFFAOYSA-N 0.000 claims 1
- UUHSCIWLHKWASR-UHFFFAOYSA-N n-(2-chlorophenyl)-2-[(2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=CC=C1F UUHSCIWLHKWASR-UHFFFAOYSA-N 0.000 claims 1
- UAGGKDBIDXINQF-UHFFFAOYSA-N n-(2-chlorophenyl)-2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 UAGGKDBIDXINQF-UHFFFAOYSA-N 0.000 claims 1
- XQRQJTFTPSFWOU-UHFFFAOYSA-N n-(2-chlorophenyl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C(=CC=CC=2)Cl)=C1 XQRQJTFTPSFWOU-UHFFFAOYSA-N 0.000 claims 1
- XSQMVRNTEIXQHY-UHFFFAOYSA-N n-(2-chlorophenyl)-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 XSQMVRNTEIXQHY-UHFFFAOYSA-N 0.000 claims 1
- RLJWLCFUCAFQED-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=CC=C1Cl RLJWLCFUCAFQED-UHFFFAOYSA-N 0.000 claims 1
- WUTHDPTYZGTKGA-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=NC=C1 WUTHDPTYZGTKGA-UHFFFAOYSA-N 0.000 claims 1
- UIKKATHXEWWFJK-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-[(2-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=CC=C1C UIKKATHXEWWFJK-UHFFFAOYSA-N 0.000 claims 1
- LXJJBEADPVAPKK-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C(=CC=CC=2)Cl)=C1 LXJJBEADPVAPKK-UHFFFAOYSA-N 0.000 claims 1
- WEXSKUATSNYNNZ-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 WEXSKUATSNYNNZ-UHFFFAOYSA-N 0.000 claims 1
- GIXKPCSMQGKZIG-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 GIXKPCSMQGKZIG-UHFFFAOYSA-N 0.000 claims 1
- CLWIDSIREQRJNU-UHFFFAOYSA-N n-(2-chlorophenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 CLWIDSIREQRJNU-UHFFFAOYSA-N 0.000 claims 1
- ABUWUMNJQJZXFY-VAWYXSNFSA-N n-(2-chlorophenyl)-4-methyl-2-[[(e)-3-phenylprop-2-enoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)\C=C\C1=CC=CC=C1 ABUWUMNJQJZXFY-VAWYXSNFSA-N 0.000 claims 1
- MXWXZGAQIIFCLX-UHFFFAOYSA-N n-(2-cyclopropylethyl)-4-methyl-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCCC2CC2)=C(C)N=C1NC(=O)C1=CC=NC=C1 MXWXZGAQIIFCLX-UHFFFAOYSA-N 0.000 claims 1
- KUALBPUGLAKVRS-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCCO)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 KUALBPUGLAKVRS-UHFFFAOYSA-N 0.000 claims 1
- LBMNMNQHFIQLAP-UHFFFAOYSA-N n-(3-chlorophenyl)-2-(cyclohexanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1CCCCC1 LBMNMNQHFIQLAP-UHFFFAOYSA-N 0.000 claims 1
- PQVVLWQRWWVNHM-UHFFFAOYSA-N n-(3-chlorophenyl)-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1CC1 PQVVLWQRWWVNHM-UHFFFAOYSA-N 0.000 claims 1
- WFICPXSSEPVFSZ-UHFFFAOYSA-N n-(3-chlorophenyl)-2-(furan-2-carbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CO1 WFICPXSSEPVFSZ-UHFFFAOYSA-N 0.000 claims 1
- QLFGFSFFPVYNOK-UHFFFAOYSA-N n-(3-chlorophenyl)-2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 QLFGFSFFPVYNOK-UHFFFAOYSA-N 0.000 claims 1
- FOPNOVRIWFTAKO-UHFFFAOYSA-N n-(3-chlorophenyl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C(Cl)C=CC=2)=C1 FOPNOVRIWFTAKO-UHFFFAOYSA-N 0.000 claims 1
- IIHVUMONYYRMLV-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=CC(Cl)=C1 IIHVUMONYYRMLV-UHFFFAOYSA-N 0.000 claims 1
- CZHNVPJOPDHZBJ-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1 CZHNVPJOPDHZBJ-UHFFFAOYSA-N 0.000 claims 1
- DKPMXZJFBLBWMW-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(2-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1C DKPMXZJFBLBWMW-UHFFFAOYSA-N 0.000 claims 1
- AMKISSMQSISXRJ-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 AMKISSMQSISXRJ-UHFFFAOYSA-N 0.000 claims 1
- PQMMHMGQADNZSS-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=C(Cl)C=CC=2)=C1 PQMMHMGQADNZSS-UHFFFAOYSA-N 0.000 claims 1
- OQDNZQUMVOPSJY-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 OQDNZQUMVOPSJY-UHFFFAOYSA-N 0.000 claims 1
- RFXFJZLFQFKLBQ-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 RFXFJZLFQFKLBQ-UHFFFAOYSA-N 0.000 claims 1
- ZKZBFAPVELTBPB-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZKZBFAPVELTBPB-UHFFFAOYSA-N 0.000 claims 1
- QRGMLNROZHGDDK-ZHACJKMWSA-N n-(3-chlorophenyl)-4-methyl-2-[[(e)-3-phenylprop-2-enoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)\C=C\C1=CC=CC=C1 QRGMLNROZHGDDK-ZHACJKMWSA-N 0.000 claims 1
- SZJQFCCIRSYGBP-UHFFFAOYSA-N n-(3-methoxyphenyl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=CC=3C=CC=CC=3)S2)C)=C1 SZJQFCCIRSYGBP-UHFFFAOYSA-N 0.000 claims 1
- HKGQRZODLXQMFV-UHFFFAOYSA-N n-(3-methoxyphenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=CC(OC)=C1 HKGQRZODLXQMFV-UHFFFAOYSA-N 0.000 claims 1
- UQGLWWLNUZENLB-UHFFFAOYSA-N n-(3-methoxyphenyl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)COC=3C=CC=CC=3)S2)C)=C1 UQGLWWLNUZENLB-UHFFFAOYSA-N 0.000 claims 1
- CZYGOUBDCOIQSJ-UHFFFAOYSA-N n-(3-methoxyphenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=CC(C)=CC=3)S2)C)=C1 CZYGOUBDCOIQSJ-UHFFFAOYSA-N 0.000 claims 1
- GTCTWZIXVZWMKY-UHFFFAOYSA-N n-(3-methoxyphenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3C=CC(=CC=3)[N+]([O-])=O)S2)C)=C1 GTCTWZIXVZWMKY-UHFFFAOYSA-N 0.000 claims 1
- FYHWKBPFGBFUNW-UHFFFAOYSA-N n-(4-bromophenyl)-2-(cyclohexanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1CCCCC1 FYHWKBPFGBFUNW-UHFFFAOYSA-N 0.000 claims 1
- JZPXVILGAJFKAO-UHFFFAOYSA-N n-(4-bromophenyl)-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1CC1 JZPXVILGAJFKAO-UHFFFAOYSA-N 0.000 claims 1
- KTSRGLNPLHBBPJ-UHFFFAOYSA-N n-(4-bromophenyl)-2-(furan-2-carbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CO1 KTSRGLNPLHBBPJ-UHFFFAOYSA-N 0.000 claims 1
- FDLKQOPEKAYJOG-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1F FDLKQOPEKAYJOG-UHFFFAOYSA-N 0.000 claims 1
- JAIJTKNLDXCMGL-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 JAIJTKNLDXCMGL-UHFFFAOYSA-N 0.000 claims 1
- MDRFMXCMTNEDJG-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=CC(Br)=CC=2)=C1 MDRFMXCMTNEDJG-UHFFFAOYSA-N 0.000 claims 1
- JIIFPOPYZNGEGG-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 JIIFPOPYZNGEGG-UHFFFAOYSA-N 0.000 claims 1
- LATCAKSBUJMAEI-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(4-tert-butylbenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C(C)(C)C)C=C1 LATCAKSBUJMAEI-UHFFFAOYSA-N 0.000 claims 1
- ZCBZPVLWHQDRMC-UHFFFAOYSA-N n-(4-bromophenyl)-2-[(5-chloro-3-methyl-1-phenylpyrazole-4-carbonyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C(=C1Cl)C(C)=NN1C1=CC=CC=C1 ZCBZPVLWHQDRMC-UHFFFAOYSA-N 0.000 claims 1
- CLGSBZDDZRITRH-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 CLGSBZDDZRITRH-UHFFFAOYSA-N 0.000 claims 1
- SCCQJINXQPTIIJ-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=C(Br)C=C1 SCCQJINXQPTIIJ-UHFFFAOYSA-N 0.000 claims 1
- YKVOLGLHELJXIP-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(2-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1C YKVOLGLHELJXIP-UHFFFAOYSA-N 0.000 claims 1
- ZHWNOASDHGPRDA-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 ZHWNOASDHGPRDA-UHFFFAOYSA-N 0.000 claims 1
- LDGKXAGLRIFNAC-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=CC(Br)=CC=2)=C1 LDGKXAGLRIFNAC-UHFFFAOYSA-N 0.000 claims 1
- XBYIEKVLTQHONT-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 XBYIEKVLTQHONT-UHFFFAOYSA-N 0.000 claims 1
- JHVJXBYWZHKTKR-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 JHVJXBYWZHKTKR-UHFFFAOYSA-N 0.000 claims 1
- MXDJJOPUKUJFOY-UHFFFAOYSA-N n-(4-bromophenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 MXDJJOPUKUJFOY-UHFFFAOYSA-N 0.000 claims 1
- SUZRELOXCNFYEG-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1CC1 SUZRELOXCNFYEG-UHFFFAOYSA-N 0.000 claims 1
- DFFYOZXGKRISEC-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(furan-2-carbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=CO1 DFFYOZXGKRISEC-UHFFFAOYSA-N 0.000 claims 1
- IIJALHFMZYCISF-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[(2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1F IIJALHFMZYCISF-UHFFFAOYSA-N 0.000 claims 1
- QQNJHGRGUVDIDQ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=CC(Cl)=CC=2)=C1 QQNJHGRGUVDIDQ-UHFFFAOYSA-N 0.000 claims 1
- ZFZKGTJZFJZBGQ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 ZFZKGTJZFJZBGQ-UHFFFAOYSA-N 0.000 claims 1
- SFCIHEYRJPOIEV-UHFFFAOYSA-N n-(4-chlorophenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=C(Cl)C=C1 SFCIHEYRJPOIEV-UHFFFAOYSA-N 0.000 claims 1
- AQAUURMRIMGFMP-UHFFFAOYSA-N n-(4-chlorophenyl)-4-methyl-2-(thiophene-2-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=CS1 AQAUURMRIMGFMP-UHFFFAOYSA-N 0.000 claims 1
- QGKIIVKNAXLNHT-UHFFFAOYSA-N n-(4-chlorophenyl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC=2C=CC(Cl)=CC=2)=C1 QGKIIVKNAXLNHT-UHFFFAOYSA-N 0.000 claims 1
- HIMVYYVDVCXAGV-UHFFFAOYSA-N n-(4-chlorophenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 HIMVYYVDVCXAGV-UHFFFAOYSA-N 0.000 claims 1
- YEAQMWCITOZLRC-UHFFFAOYSA-N n-(4-chlorophenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 YEAQMWCITOZLRC-UHFFFAOYSA-N 0.000 claims 1
- IBSHTCOEQNPGPV-KPKJPENVSA-N n-(4-chlorophenyl)-4-methyl-2-[[(e)-3-phenylprop-2-enoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)\C=C\C1=CC=CC=C1 IBSHTCOEQNPGPV-KPKJPENVSA-N 0.000 claims 1
- HQKZPNXRCGYYHE-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=CC=2C=CC=CC=2)S1 HQKZPNXRCGYYHE-UHFFFAOYSA-N 0.000 claims 1
- UOKLIHKRUSOMDB-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1=CC=C(OC)C=C1 UOKLIHKRUSOMDB-UHFFFAOYSA-N 0.000 claims 1
- AQQMGQUVJIXQRR-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)COC=2C=CC=CC=2)S1 AQQMGQUVJIXQRR-UHFFFAOYSA-N 0.000 claims 1
- VTYFQQBJXDGROO-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=C(OC)C(OC)=C(OC)C=2)S1 VTYFQQBJXDGROO-UHFFFAOYSA-N 0.000 claims 1
- HQSRTCBOOUZBAI-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC(C)=CC=2)S1 HQSRTCBOOUZBAI-UHFFFAOYSA-N 0.000 claims 1
- AZOAIICBHAIJDT-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-methyl-2-[(4-nitrobenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2C=CC(=CC=2)[N+]([O-])=O)S1 AZOAIICBHAIJDT-UHFFFAOYSA-N 0.000 claims 1
- OYHOEDBNAJPFKK-UHFFFAOYSA-N n-(4-oxo-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-c]azepin-2-yl)acetamide Chemical compound C1CCNC(=O)C2=C1N=C(NC(=O)C)S2 OYHOEDBNAJPFKK-UHFFFAOYSA-N 0.000 claims 1
- NNDYLNJPPOWVDS-UHFFFAOYSA-N n-(4-oxo-5,6,7,8-tetrahydro-[1,3]thiazolo[5,4-c]azepin-2-yl)benzamide Chemical compound N=1C=2CCCNC(=O)C=2SC=1NC(=O)C1=CC=CC=C1 NNDYLNJPPOWVDS-UHFFFAOYSA-N 0.000 claims 1
- QRQKSPKJHPMRSQ-UHFFFAOYSA-N n-(7,7-dimethyl-4-oxo-6,8-dihydro-5h-[1,3]thiazolo[5,4-c]azepin-2-yl)acetamide Chemical compound C1C(C)(C)CNC(=O)C2=C1N=C(NC(=O)C)S2 QRQKSPKJHPMRSQ-UHFFFAOYSA-N 0.000 claims 1
- RCCMCGBQXZHEHI-UHFFFAOYSA-N n-(7,7-dimethyl-4-oxo-6,8-dihydro-5h-[1,3]thiazolo[5,4-c]azepin-2-yl)benzamide Chemical compound N=1C=2CC(C)(C)CNC(=O)C=2SC=1NC(=O)C1=CC=CC=C1 RCCMCGBQXZHEHI-UHFFFAOYSA-N 0.000 claims 1
- JSKASTNPLROEED-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1CC1 JSKASTNPLROEED-UHFFFAOYSA-N 0.000 claims 1
- XPSHGITYDVVGOM-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-4-methyl-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1 XPSHGITYDVVGOM-UHFFFAOYSA-N 0.000 claims 1
- JDHJLGWWCHTRDK-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)NCCN(C)C)SC(NC(=O)C=CC=2C=CC=CC=2)=N1 JDHJLGWWCHTRDK-UHFFFAOYSA-N 0.000 claims 1
- RIELSYYBKTZOKY-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)NCCN(C)C)SC(NC(=O)C=2C=CC(C)=CC=2)=N1 RIELSYYBKTZOKY-UHFFFAOYSA-N 0.000 claims 1
- BBECJODDHDKTGH-UHFFFAOYSA-N n-[4-methyl-5-(morpholine-4-carbonyl)-1,3-thiazol-2-yl]-3-phenylprop-2-enamide Chemical compound S1C(C(=O)N2CCOCC2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 BBECJODDHDKTGH-UHFFFAOYSA-N 0.000 claims 1
- XABDPXZZLJXIPG-UHFFFAOYSA-N n-[4-methyl-5-(morpholine-4-carbonyl)-1,3-thiazol-2-yl]-4-nitrobenzamide Chemical compound S1C(C(=O)N2CCOCC2)=C(C)N=C1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 XABDPXZZLJXIPG-UHFFFAOYSA-N 0.000 claims 1
- POXNCKHKKKIBHI-UHFFFAOYSA-N n-[4-methyl-5-(morpholine-4-carbonyl)-1,3-thiazol-2-yl]propanamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)N1CCOCC1 POXNCKHKKKIBHI-UHFFFAOYSA-N 0.000 claims 1
- DORXKEGDOMLQFE-UHFFFAOYSA-N n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]-2-phenoxyacetamide Chemical compound S1C(C(=O)N2CCCCC2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 DORXKEGDOMLQFE-UHFFFAOYSA-N 0.000 claims 1
- LLWDWAJULFQQHS-UHFFFAOYSA-N n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]-3-phenylprop-2-enamide Chemical compound S1C(C(=O)N2CCCCC2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 LLWDWAJULFQQHS-UHFFFAOYSA-N 0.000 claims 1
- OASSPGFDHKQHSO-UHFFFAOYSA-N n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C(=O)N2CCCCC2)=C(C)N=C1NC(=O)C1=CC=CC=C1 OASSPGFDHKQHSO-UHFFFAOYSA-N 0.000 claims 1
- NJEDZJRAVIOQJA-UHFFFAOYSA-N n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide Chemical compound S1C(C(=O)N2CCCCC2)=C(C)N=C1NC(=O)C1CC1 NJEDZJRAVIOQJA-UHFFFAOYSA-N 0.000 claims 1
- QXYOPOBEQNQGPJ-UHFFFAOYSA-N n-[4-methyl-5-(piperidine-1-carbonyl)-1,3-thiazol-2-yl]propanamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)N1CCCCC1 QXYOPOBEQNQGPJ-UHFFFAOYSA-N 0.000 claims 1
- YDHGFBRDUMQPRG-UHFFFAOYSA-N n-[5-(2,3-dihydro-1,4-benzodioxin-6-ylcarbamoyl)-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3OCCOC3=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 YDHGFBRDUMQPRG-UHFFFAOYSA-N 0.000 claims 1
- DFRBZYZORDKPNL-UHFFFAOYSA-N n-[5-(2,3-dihydro-1h-inden-5-ylcarbamoyl)-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C3CCCC3=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 DFRBZYZORDKPNL-UHFFFAOYSA-N 0.000 claims 1
- WAZMXQONRUETQO-UHFFFAOYSA-N n-[5-(benzylcarbamoyl)-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 WAZMXQONRUETQO-UHFFFAOYSA-N 0.000 claims 1
- DWYCAWAEJVVQDG-UHFFFAOYSA-N n-[5-(cyclohexylcarbamoyl)-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 DWYCAWAEJVVQDG-UHFFFAOYSA-N 0.000 claims 1
- AOBFZZWETFIKJP-UHFFFAOYSA-N n-[5-(imidazole-1-carbonyl)-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C(=O)N2C=NC=C2)=C(C)N=C1NC(=O)C1=CC=CC=C1 AOBFZZWETFIKJP-UHFFFAOYSA-N 0.000 claims 1
- FKDBOTGPLGJRNZ-UHFFFAOYSA-N n-[5-[(2-chlorophenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C(=CC=CC=2)Cl)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 FKDBOTGPLGJRNZ-UHFFFAOYSA-N 0.000 claims 1
- QSVHCDCEQINMIN-UHFFFAOYSA-N n-[5-[(3-chlorophenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=C(Cl)C=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 QSVHCDCEQINMIN-UHFFFAOYSA-N 0.000 claims 1
- DQLGJOGHVXWKQH-UHFFFAOYSA-N n-[5-[(3-methoxyphenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(N=C(NC(=O)C=3SC=4N(C=5C=CC=CC=5)N=C(C)C=4C=3)S2)C)=C1 DQLGJOGHVXWKQH-UHFFFAOYSA-N 0.000 claims 1
- SNSGKJYKGHWOPS-UHFFFAOYSA-N n-[5-[(4-bromophenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Br)=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 SNSGKJYKGHWOPS-UHFFFAOYSA-N 0.000 claims 1
- QVXMNIAQBCYENR-UHFFFAOYSA-N n-[5-[(4-chlorophenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound S1C(C(=O)NC=2C=CC(Cl)=CC=2)=C(C)N=C1NC(=O)C(SC=12)=CC=1C(C)=NN2C1=CC=CC=C1 QVXMNIAQBCYENR-UHFFFAOYSA-N 0.000 claims 1
- YFUHOBPLFPXHSR-UHFFFAOYSA-N n-[5-[(4-methoxyphenyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]-3-methyl-1-phenylthieno[2,3-c]pyrazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C(C)N=C(NC(=O)C=2SC=3N(C=4C=CC=CC=4)N=C(C)C=3C=2)S1 YFUHOBPLFPXHSR-UHFFFAOYSA-N 0.000 claims 1
- UTQXCUUAKSBTKL-UHFFFAOYSA-N n-[5-[amino(benzoyl)carbamoyl]-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound S1C(C(=O)N(N)C(=O)C=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1 UTQXCUUAKSBTKL-UHFFFAOYSA-N 0.000 claims 1
- MVRKMIBKFPAHHJ-UHFFFAOYSA-N n-benzyl-2-(2,2-dimethylpropanoylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound N1=C(NC(=O)C(C)(C)C)SC(C(=O)NCC=2C=CC=CC=2)=C1C MVRKMIBKFPAHHJ-UHFFFAOYSA-N 0.000 claims 1
- UASDXHCLBKRPDH-UHFFFAOYSA-N n-benzyl-2-(benzylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NCC1=CC=CC=C1 UASDXHCLBKRPDH-UHFFFAOYSA-N 0.000 claims 1
- GNXKFBIOKRDWRR-UHFFFAOYSA-N n-benzyl-2-(cyclobutanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CCC1 GNXKFBIOKRDWRR-UHFFFAOYSA-N 0.000 claims 1
- RGJRCXZESVXGCE-UHFFFAOYSA-N n-benzyl-2-(cyclohexanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CCCCC1 RGJRCXZESVXGCE-UHFFFAOYSA-N 0.000 claims 1
- STWXSLGWGDBHBU-UHFFFAOYSA-N n-benzyl-2-(cyclopentanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CCCC1 STWXSLGWGDBHBU-UHFFFAOYSA-N 0.000 claims 1
- GCMXBJVRGMPLSE-UHFFFAOYSA-N n-benzyl-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CC1 GCMXBJVRGMPLSE-UHFFFAOYSA-N 0.000 claims 1
- FSLNQLRDNLQOMU-UHFFFAOYSA-N n-benzyl-2-[(2,4-dichlorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Cl)C=C1Cl FSLNQLRDNLQOMU-UHFFFAOYSA-N 0.000 claims 1
- JXAJFOMFRKOBFK-UHFFFAOYSA-N n-benzyl-2-[(2,5-difluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC(F)=CC=C1F JXAJFOMFRKOBFK-UHFFFAOYSA-N 0.000 claims 1
- PRMLTFZQZCJQRW-UHFFFAOYSA-N n-benzyl-2-[(2-chloro-4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1Cl PRMLTFZQZCJQRW-UHFFFAOYSA-N 0.000 claims 1
- PDTXVYPSOVXRFP-UHFFFAOYSA-N n-benzyl-2-[(2-chlorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1Cl PDTXVYPSOVXRFP-UHFFFAOYSA-N 0.000 claims 1
- QARWGMOTQSTCTA-UHFFFAOYSA-N n-benzyl-2-[(2-cyclopropylacetyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CC1CC1 QARWGMOTQSTCTA-UHFFFAOYSA-N 0.000 claims 1
- PDEBLZNLPOEPSJ-UHFFFAOYSA-N n-benzyl-2-[(2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1F PDEBLZNLPOEPSJ-UHFFFAOYSA-N 0.000 claims 1
- UPHNYCKAMMVEKI-UHFFFAOYSA-N n-benzyl-2-[(2-methoxypyridine-4-carbonyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=NC(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NCC=2C=CC=CC=2)=C1 UPHNYCKAMMVEKI-UHFFFAOYSA-N 0.000 claims 1
- FFCGZTMVUSQZQJ-UHFFFAOYSA-N n-benzyl-2-[(3,5-dichlorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC(Cl)=CC(Cl)=C1 FFCGZTMVUSQZQJ-UHFFFAOYSA-N 0.000 claims 1
- QZEWLEMAXYVHMQ-UHFFFAOYSA-N n-benzyl-2-[(3,5-difluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC(F)=CC(F)=C1 QZEWLEMAXYVHMQ-UHFFFAOYSA-N 0.000 claims 1
- ZHLKHOSOEZHULD-UHFFFAOYSA-N n-benzyl-2-[(3-chlorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(Cl)=C1 ZHLKHOSOEZHULD-UHFFFAOYSA-N 0.000 claims 1
- GHVHTMHPONITMN-UHFFFAOYSA-N n-benzyl-2-[(3-cyanobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C#N)=C1 GHVHTMHPONITMN-UHFFFAOYSA-N 0.000 claims 1
- CKIRBBJGXMZZCU-UHFFFAOYSA-N n-benzyl-2-[(3-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(F)=C1 CKIRBBJGXMZZCU-UHFFFAOYSA-N 0.000 claims 1
- WMRKNDHXDGUQMI-UHFFFAOYSA-N n-benzyl-2-[(3-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound COC1=CC=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NCC=2C=CC=CC=2)=C1 WMRKNDHXDGUQMI-UHFFFAOYSA-N 0.000 claims 1
- XLBMZNPPSHMRSZ-UHFFFAOYSA-N n-benzyl-2-[(4-benzylbenzoyl)amino]-4-(diethylaminomethyl)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(CN(CC)CC)N=C1NC(=O)C(C=C1)=CC=C1CC1=CC=CC=C1 XLBMZNPPSHMRSZ-UHFFFAOYSA-N 0.000 claims 1
- XLXCGWJDXQMDCW-UHFFFAOYSA-N n-benzyl-2-[(4-bromobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1 XLXCGWJDXQMDCW-UHFFFAOYSA-N 0.000 claims 1
- KIYWQSVKWCLYKS-UHFFFAOYSA-N n-benzyl-2-[(4-chlorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Cl)C=C1 KIYWQSVKWCLYKS-UHFFFAOYSA-N 0.000 claims 1
- KWNYBAYKZCFOLQ-UHFFFAOYSA-N n-benzyl-2-[(4-chlorophenyl)carbamoylamino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)NC1=CC=C(Cl)C=C1 KWNYBAYKZCFOLQ-UHFFFAOYSA-N 0.000 claims 1
- DYDBVXKCAUNBFQ-UHFFFAOYSA-N n-benzyl-2-[(4-cyanobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C#N)C=C1 DYDBVXKCAUNBFQ-UHFFFAOYSA-N 0.000 claims 1
- QMFQIOWYPDLSML-UHFFFAOYSA-N n-benzyl-2-[(4-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(F)C=C1 QMFQIOWYPDLSML-UHFFFAOYSA-N 0.000 claims 1
- BUBQDTNCDOLSMX-UHFFFAOYSA-N n-benzyl-2-[(4-fluorophenyl)carbamoylamino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)NC1=CC=C(F)C=C1 BUBQDTNCDOLSMX-UHFFFAOYSA-N 0.000 claims 1
- PHLCBAMFRFJOEW-UHFFFAOYSA-N n-benzyl-2-[(4-methoxybenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=NC(C)=C(C(=O)NCC=2C=CC=CC=2)S1 PHLCBAMFRFJOEW-UHFFFAOYSA-N 0.000 claims 1
- LDQVEQSWMDYCII-UHFFFAOYSA-N n-benzyl-2-[(4-pentylbenzoyl)amino]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide Chemical compound C1=CC(CCCCC)=CC=C1C(=O)NC1=NC(C(F)(F)F)=C(C(=O)NCC=2C=CC=CC=2)S1 LDQVEQSWMDYCII-UHFFFAOYSA-N 0.000 claims 1
- LCBRRWNVGYUXRU-UHFFFAOYSA-N n-benzyl-2-[(5-chloro-2-fluorobenzoyl)amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC(Cl)=CC=C1F LCBRRWNVGYUXRU-UHFFFAOYSA-N 0.000 claims 1
- MYMQZRRKCFLLEN-UHFFFAOYSA-N n-benzyl-2-[[4-bromo-2-(hydroxymethyl)benzoyl]amino]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(Br)C=C1CO MYMQZRRKCFLLEN-UHFFFAOYSA-N 0.000 claims 1
- ZVQLNEXDYISYHD-UHFFFAOYSA-N n-benzyl-4-(morpholin-4-ylmethyl)-2-(3-phenylpropanoylamino)-1,3-thiazole-5-carboxamide Chemical compound N=1C(CN2CCOCC2)=C(C(=O)NCC=2C=CC=CC=2)SC=1NC(=O)CCC1=CC=CC=C1 ZVQLNEXDYISYHD-UHFFFAOYSA-N 0.000 claims 1
- CULAFBACLOBTJC-UHFFFAOYSA-N n-benzyl-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 CULAFBACLOBTJC-UHFFFAOYSA-N 0.000 claims 1
- CRQQIAXGJDZEEP-UHFFFAOYSA-N n-benzyl-4-methyl-2-(3-phenylpropanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CCC1=CC=CC=C1 CRQQIAXGJDZEEP-UHFFFAOYSA-N 0.000 claims 1
- GVHKFQWZIZVQNC-UHFFFAOYSA-N n-benzyl-4-methyl-2-(4-phenylbutanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CCCC1=CC=CC=C1 GVHKFQWZIZVQNC-UHFFFAOYSA-N 0.000 claims 1
- PZBLGSLRQRNAMQ-UHFFFAOYSA-N n-benzyl-4-methyl-2-(5-phenylpentanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CCCCC1=CC=CC=C1 PZBLGSLRQRNAMQ-UHFFFAOYSA-N 0.000 claims 1
- UNIDIJFNURKKOZ-UHFFFAOYSA-N n-benzyl-4-methyl-2-(naphthalene-1-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound CC=1N=C(NC(=O)C=2C3=CC=CC=C3C=CC=2)SC=1C(=O)NCC1=CC=CC=C1 UNIDIJFNURKKOZ-UHFFFAOYSA-N 0.000 claims 1
- IXHSNSIWQFBTOR-UHFFFAOYSA-N n-benzyl-4-methyl-2-(phenylcarbamoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)NC1=CC=CC=C1 IXHSNSIWQFBTOR-UHFFFAOYSA-N 0.000 claims 1
- PJLFZTTXYDPKIQ-UHFFFAOYSA-N n-benzyl-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NCC1=CC=CC=C1 PJLFZTTXYDPKIQ-UHFFFAOYSA-N 0.000 claims 1
- PWLUJTQSASXMKY-UHFFFAOYSA-N n-benzyl-4-methyl-2-(pyridine-3-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CN=C1 PWLUJTQSASXMKY-UHFFFAOYSA-N 0.000 claims 1
- IIMDQPAMKXXWEG-UHFFFAOYSA-N n-benzyl-4-methyl-2-(pyridine-4-carbonylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=NC=C1 IIMDQPAMKXXWEG-UHFFFAOYSA-N 0.000 claims 1
- HMWGBENLUHCHHA-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-methylsulfonylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1S(C)(=O)=O HMWGBENLUHCHHA-UHFFFAOYSA-N 0.000 claims 1
- HLORSNJQDAXVFN-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-oxo-1-phenylpyridine-4-carbonyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C(=CC1=O)C=CN1C1=CC=CC=C1 HLORSNJQDAXVFN-UHFFFAOYSA-N 0.000 claims 1
- IDTHMOSXZDFRNK-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-oxo-1h-pyridine-4-carbonyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C=1C=CNC(=O)C=1 IDTHMOSXZDFRNK-UHFFFAOYSA-N 0.000 claims 1
- GNRPNPRUGLIATK-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-phenoxyacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)COC1=CC=CC=C1 GNRPNPRUGLIATK-UHFFFAOYSA-N 0.000 claims 1
- XNDFTRNFNLLUBC-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-phenylacetyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)CC1=CC=CC=C1 XNDFTRNFNLLUBC-UHFFFAOYSA-N 0.000 claims 1
- BLPSVEXSZCEXFP-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(2-phenylcyclopropanecarbonyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1CC1C1=CC=CC=C1 BLPSVEXSZCEXFP-UHFFFAOYSA-N 0.000 claims 1
- CITOIFPUVSDXJV-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(3-methylsulfonylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(S(C)(=O)=O)=C1 CITOIFPUVSDXJV-UHFFFAOYSA-N 0.000 claims 1
- ABILDASRLDDBRU-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 ABILDASRLDDBRU-UHFFFAOYSA-N 0.000 claims 1
- FUMVOCOQWCXQIX-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(4-methylphenyl)sulfonylamino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NS(=O)(=O)C1=CC=C(C)C=C1 FUMVOCOQWCXQIX-UHFFFAOYSA-N 0.000 claims 1
- ZEDNRRDVENYNMS-UHFFFAOYSA-N n-benzyl-4-methyl-2-[(4-methylsulfonylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(S(C)(=O)=O)C=C1 ZEDNRRDVENYNMS-UHFFFAOYSA-N 0.000 claims 1
- PZNPCEAFPBABDV-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[2-(trifluoromethoxy)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1OC(F)(F)F PZNPCEAFPBABDV-UHFFFAOYSA-N 0.000 claims 1
- UMYBKNRMIGIODC-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[2-(trifluoromethyl)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC=C1C(F)(F)F UMYBKNRMIGIODC-UHFFFAOYSA-N 0.000 claims 1
- KLJXPGPPZGRRQJ-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[3-(trifluoromethoxy)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(OC(F)(F)F)=C1 KLJXPGPPZGRRQJ-UHFFFAOYSA-N 0.000 claims 1
- BWBDKZKVUKSMBT-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[3-(trifluoromethyl)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 BWBDKZKVUKSMBT-UHFFFAOYSA-N 0.000 claims 1
- VYXBXLDDXONFGY-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[4-(2-oxopyridin-1-yl)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C(C=C1)=CC=C1N1C=CC=CC1=O VYXBXLDDXONFGY-UHFFFAOYSA-N 0.000 claims 1
- QQAGAKZSFRNLJT-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[4-(2h-tetrazol-5-yl)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C(C=C1)=CC=C1C=1N=NNN=1 QQAGAKZSFRNLJT-UHFFFAOYSA-N 0.000 claims 1
- ACYDLNLJTFEXPO-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[4-(trifluoromethoxy)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(OC(F)(F)F)C=C1 ACYDLNLJTFEXPO-UHFFFAOYSA-N 0.000 claims 1
- AJUWIRBQPBCTOM-UHFFFAOYSA-N n-benzyl-4-methyl-2-[[4-(trifluoromethyl)benzoyl]amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC=2C=CC=CC=2)=C(C)N=C1NC(=O)C1=CC=C(C(F)(F)F)C=C1 AJUWIRBQPBCTOM-UHFFFAOYSA-N 0.000 claims 1
- NZCIQXYBXKGMNX-UHFFFAOYSA-N n-cyclohexyl-2-(cyclopropanecarbonylamino)-4-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1CC1 NZCIQXYBXKGMNX-UHFFFAOYSA-N 0.000 claims 1
- RNDCRLKFJASAKU-UHFFFAOYSA-N n-cyclohexyl-4-methyl-2-(3-phenylprop-2-enoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C=CC1=CC=CC=C1 RNDCRLKFJASAKU-UHFFFAOYSA-N 0.000 claims 1
- RRJYRLPUJGQLID-UHFFFAOYSA-N n-cyclohexyl-4-methyl-2-(propanoylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NC(=O)CC)=NC(C)=C1C(=O)NC1CCCCC1 RRJYRLPUJGQLID-UHFFFAOYSA-N 0.000 claims 1
- WPFDWGOOONLNAT-UHFFFAOYSA-N n-cyclohexyl-4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2SC(=C(C)N=2)C(=O)NC2CCCCC2)=C1 WPFDWGOOONLNAT-UHFFFAOYSA-N 0.000 claims 1
- QUCAQBJMPOINFV-UHFFFAOYSA-N n-cyclohexyl-4-methyl-2-[(3-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1=CC=CC(C)=C1 QUCAQBJMPOINFV-UHFFFAOYSA-N 0.000 claims 1
- YBIOAXJHNHVCDZ-UHFFFAOYSA-N n-cyclohexyl-4-methyl-2-[(4-methylbenzoyl)amino]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC2CCCCC2)=C(C)N=C1NC(=O)C1=CC=C(C)C=C1 YBIOAXJHNHVCDZ-UHFFFAOYSA-N 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000036573 scar formation Effects 0.000 claims 1
- 239000004059 squalene synthase inhibitor Substances 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 201000005665 thrombophilia Diseases 0.000 claims 1
- 208000016261 weight loss Diseases 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68713305P | 2005-06-03 | 2005-06-03 | |
| PCT/US2006/021660 WO2007130075A1 (en) | 2005-06-03 | 2006-06-05 | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013042546A Division JP2013100376A (ja) | 2005-06-03 | 2013-03-05 | ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009513563A JP2009513563A (ja) | 2009-04-02 |
| JP2009513563A5 true JP2009513563A5 (enExample) | 2009-07-02 |
Family
ID=37067442
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525998A Pending JP2009513563A (ja) | 2005-06-03 | 2006-06-05 | ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体 |
| JP2013042546A Pending JP2013100376A (ja) | 2005-06-03 | 2013-03-05 | ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013042546A Pending JP2013100376A (ja) | 2005-06-03 | 2013-03-05 | ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8541457B2 (enExample) |
| EP (2) | EP2540296A1 (enExample) |
| JP (2) | JP2009513563A (enExample) |
| CN (1) | CN101208089A (enExample) |
| AU (1) | AU2006343359A1 (enExample) |
| BR (1) | BRPI0611187A2 (enExample) |
| CA (1) | CA2618646A1 (enExample) |
| MX (1) | MX2007015216A (enExample) |
| WO (1) | WO2007130075A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| JP4958785B2 (ja) | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体およびステアロイル−CoAデサチュラーゼインヒビターとしてのそれらの使用 |
| AU2005286728A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| WO2006034441A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| BRPI0515483A (pt) * | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
| TW200626155A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| CN101084211A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| AU2005286790A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD) |
| WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
| WO2008139845A1 (ja) * | 2007-04-24 | 2008-11-20 | Daiichi Sankyo Company, Limited | 新規アミド誘導体 |
| PT2178852E (pt) | 2007-08-03 | 2015-11-12 | Romark Lab Lc | Compostos tiazolida substituídos com alquilsulfonilo |
| MX2010009158A (es) * | 2008-02-20 | 2010-09-24 | Novartis Ag | Inhibidores heterociclicos de estearoil-coa-desaturasa. |
| EA201001358A1 (ru) * | 2008-02-25 | 2011-04-29 | Мерк Патент Гмбх | Активаторы глюкокиназы |
| NZ589962A (en) * | 2008-06-27 | 2012-12-21 | Novartis Ag | Inhibitors of stearoyl-CoA desaturase and uses thereof |
| US20100113520A1 (en) * | 2008-11-05 | 2010-05-06 | Principia Biopharma, Inc. | Kinase knockdown via electrophilically enhanced inhibitors |
| AU2010215035B2 (en) | 2009-02-17 | 2014-06-12 | Merck Canada Inc. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| PE20121118A1 (es) | 2009-05-12 | 2012-09-05 | Romark Lab Lc | Compuestos de haloalquil heteroaril benzamida |
| US9023877B2 (en) | 2009-06-26 | 2015-05-05 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
| WO2011011872A1 (en) | 2009-07-28 | 2011-02-03 | Merck Frosst Canada Ltd. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| KR101898610B1 (ko) | 2010-08-31 | 2018-09-14 | 서울대학교산학협력단 | PPARδ 활성물질의 태자 재프로그래밍 용도 |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| BR112014008590A2 (pt) | 2011-10-15 | 2017-10-24 | Genentech Inc | métodos de uso de antagonistas de scd1 |
| US9233102B2 (en) | 2012-03-07 | 2016-01-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| JP6293127B2 (ja) | 2012-05-22 | 2018-03-14 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド | 未分化細胞の選択的阻害剤 |
| HK1211942A1 (en) | 2012-09-10 | 2016-06-03 | Principia Biopharma Inc. | Pyrazolopyrimidine compounds as kinase inhibitors |
| CN102977049A (zh) * | 2012-11-26 | 2013-03-20 | 盛世泰科生物医药技术(苏州)有限公司 | 一种2-氨基-4-环丙基-5-羧酸乙酯噻唑的合成方法 |
| MX372673B (es) | 2014-02-21 | 2020-03-25 | Principia Biopharma Inc | Un inhibidor de btk para usarse en el tratamiento de penfigo y sales y formas sólidas del mismo. |
| US10301273B2 (en) | 2014-08-07 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| PT3233103T (pt) | 2014-12-18 | 2021-01-18 | Principia Biopharma Inc | Tratamento de pênfigo |
| MA42242A (fr) | 2015-06-24 | 2018-05-02 | Principia Biopharma Inc | Inhibiteurs de la tyrosine kinase |
| RU2018120308A (ru) * | 2015-12-11 | 2019-12-03 | Тейдзин Фарма Лимитед | Производное аминоазола |
| CN107089955B (zh) * | 2016-02-18 | 2020-10-23 | 广东东阳光药业有限公司 | 磺酰胺类衍生物及其制备方法和用途 |
| ES2928408T3 (es) | 2016-04-11 | 2022-11-17 | Genfit | Métodos para el tratamiento de enfermedades fibróticas |
| WO2017178174A1 (en) * | 2016-04-11 | 2017-10-19 | Genfit | Methods of treatment of cholestasis and fibrosis |
| EA201892836A1 (ru) | 2016-06-29 | 2019-07-31 | Принсипиа Биофарма Инк. | Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением |
| CN117777121A (zh) | 2016-10-24 | 2024-03-29 | 詹森药业有限公司 | 化合物及其用途 |
| EA201991650A1 (ru) | 2017-01-06 | 2020-01-20 | Юманити Терапьютикс, Инк. | Способы лечения неврологических расстройств |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| AU2019238326B2 (en) | 2018-03-23 | 2025-03-06 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| JP7742775B2 (ja) | 2019-01-24 | 2025-09-22 | ヤンセン ファーマシューティカ エヌ.ベー. | 化合物及びその使用 |
| MX2022004427A (es) | 2019-10-14 | 2022-07-12 | Principia Biopharma Inc | Metodos para el tratamiento de la trombocitopenia inmunitaria mediante la administracion de (r)-2-[3-[4-amino-3-(2-fluoro-4-feno xi-fenil)pirazolo[3,4-d]pirimidin-1-il]piperidino-1-carbonil]-4-m etil-4-[4-(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo. |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| MX2022009009A (es) | 2020-01-22 | 2022-08-15 | Principia Biopharma Inc | Formas cristalinas de 2-[3-[4-amino-3-(2-fluoro-4-fenoxi-fenil)-1h -pirazolo[3,4-d]pirimidin-1-il]piperidin-1-carbonil]-4-metil-4-[4 -(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo. |
| CN120093741A (zh) | 2020-04-24 | 2025-06-06 | 拜耳公司 | 作为dgkzeta抑制剂用于免疫活化的取代的氨基噻唑 |
| WO2024235205A1 (zh) * | 2023-05-12 | 2024-11-21 | 上海翰森生物医药科技有限公司 | 噻唑类衍生物抑制剂、其制备方法和应用 |
Family Cites Families (307)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
| DE1670684A1 (de) * | 1966-04-01 | 1970-12-03 | Hoechst Ag | Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten |
| US3830924A (en) | 1966-12-23 | 1974-08-20 | American Cyanamid Co | Substituted nitroimidazolyl-thiadiazoles as growth promoting agents |
| US3830914A (en) * | 1970-08-04 | 1974-08-20 | Us Agriculture | Micro-encapsulated insecticide feed-additive for control of fly larvae in cow manure |
| AT340933B (de) * | 1973-08-20 | 1978-01-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze |
| DE2341925A1 (de) | 1973-08-20 | 1975-03-06 | Thomae Gmbh Dr K | Neue pyrimidinderivate und verfahren zu ihrer herstellung |
| DE2427943C2 (de) | 1974-06-10 | 1984-08-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE2516040C2 (de) | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| NL171985C (nl) | 1976-02-10 | 1983-06-16 | Rhone Poulenc Ind | Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen. |
| EP0009655B1 (en) | 1978-10-02 | 1983-05-11 | Gruppo Lepetit S.P.A. | 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them |
| US4247551A (en) * | 1979-09-17 | 1981-01-27 | Gruppo Lepetit S.P.A. | N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents |
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| CH653021A5 (fr) * | 1981-04-24 | 1985-12-13 | Delalande Sa | Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant. |
| US4439606A (en) * | 1982-05-06 | 1984-03-27 | American Cyanamid Company | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| CH655103A5 (de) | 1983-03-11 | 1986-03-27 | Sandoz Ag | Azolderivate, verfahren zu ihrer herstellung und ihre verwendung. |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| ATE77817T1 (de) | 1985-04-30 | 1992-07-15 | Dresden Arzneimittel | 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. |
| ES8802151A1 (es) | 1985-07-31 | 1988-04-01 | Janssen Pharmaceutica Nv | Un procedimiento para la preparacion de nuevos piridazinaminas. |
| DE3536030A1 (de) | 1985-10-09 | 1987-04-09 | Thomae Gmbh Dr K | Verwendung von benzimidazolen zur behandlung der migraene |
| AU1704588A (en) | 1987-04-03 | 1988-11-02 | Upjohn Company, The | Amino-9,10-secosteroids |
| CA1338012C (en) | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| NZ225045A (en) | 1987-07-01 | 1990-06-26 | Janssen Pharmaceutica Nv | Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent |
| MY104343A (en) | 1987-11-23 | 1994-03-31 | Janssen Pharmaceutica Nv | Novel pyridizinamine deravatives |
| DE3827599A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Verwendung von optisch aktiven tetrahydrofuran-2-carbonsaeureestern als dotierstoffe in fluessigkristallmischungen, diese enthaltende fluessigkristallmischungen und neue optisch aktive tetrahydrofuran-2-carbonsaeureester |
| US4994456A (en) | 1989-03-01 | 1991-02-19 | Nisshin Flour Milling Co., Ltd. | Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| WO1991009849A1 (en) | 1989-12-28 | 1991-07-11 | The Upjohn Company | Diaromatic substituted anti-aids compounds |
| AU658134B2 (en) | 1989-12-28 | 1995-04-06 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
| IL96891A0 (en) | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
| US5166147A (en) * | 1990-07-09 | 1992-11-24 | The Du Pont Merck Pharmaceutical Company | 4-heteroaryl-and 4-aryl-1,4-dihydropyridine, derivatives with calcium agonist and alpha1 -antagonist activity |
| EP0471201A1 (de) * | 1990-07-21 | 1992-02-19 | Hoechst Aktiengesellschaft | Neue Oxazolidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| DE4031000A1 (de) | 1990-10-01 | 1992-04-09 | Hoechst Ag | 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel |
| IT1245712B (it) | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
| FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| EP0520292A1 (de) * | 1991-06-19 | 1992-12-30 | Hoechst Aktiengesellschaft | Chirale Azetidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| CA2111957A1 (en) | 1991-06-27 | 1993-01-07 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
| AU653855B2 (en) | 1991-07-03 | 1994-10-13 | Pharmacia & Upjohn Company | Indolyl carbonyl pyridinyl-poperazine/piperidine derivatives |
| EP0524146A1 (de) | 1991-07-19 | 1993-01-20 | Ciba-Geigy Ag | Aminosubstituierte Piperazinderivate |
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| GB9117639D0 (en) | 1991-08-15 | 1991-10-02 | Ici Plc | Therapeutic compounds |
| JPH05255089A (ja) | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| JPH05345780A (ja) * | 1991-12-24 | 1993-12-27 | Kumiai Chem Ind Co Ltd | ピリミジンまたはトリアジン誘導体及び除草剤 |
| AU3351293A (en) | 1992-01-21 | 1993-08-03 | Glaxo Group Limited | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| WO1993018016A1 (en) | 1992-03-11 | 1993-09-16 | E.I. Du Pont De Nemours And Company | Fungicidal oxazolidinones |
| HU209678B (en) | 1992-06-09 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them |
| IT1255704B (it) | 1992-09-30 | 1995-11-10 | Boehringer Mannheim Italia | Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree |
| DE4236106A1 (de) * | 1992-10-26 | 1994-04-28 | Hoechst Ag | Azaaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssigkristallinen Mischungen |
| US5494908A (en) | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| US5380726A (en) * | 1993-01-15 | 1995-01-10 | Ciba-Geigy Corporation | Substituted dialkylthio ethers |
| DE4302051A1 (de) | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| JP3377826B2 (ja) | 1993-05-06 | 2003-02-17 | ヘキスト・アクチェンゲゼルシャフト | 液晶組成物に使用するための新規化合物 |
| US5547605A (en) * | 1993-12-15 | 1996-08-20 | Hoechst Aktiengesellschaft | 2-Aryloxytetrafluoropropionic esters, process for their preparation, and their use in liquid-crystalline mixtures |
| DE4343286A1 (de) | 1993-12-17 | 1995-06-22 | Hoechst Ag | Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19502178A1 (de) | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| US5464788A (en) | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| DE4423044A1 (de) | 1994-07-01 | 1996-01-04 | Hoechst Ag | 1-(3-Alkyloxiran-2-yl)alkylester mesogener Carbonsäuren und ihre Verwendung in flüssigkristallinen Mischungen |
| US5607932A (en) | 1994-07-12 | 1997-03-04 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of azolones |
| US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
| US5637592A (en) | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| PT788511E (pt) | 1994-10-07 | 2003-04-30 | Fujisawa Pharmaceutical Co | Hexapeptidos ciclicos com actividade antibiotica |
| US5702637A (en) | 1995-04-19 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Liquid crystal compounds having a chiral fluorinated terminal portion |
| US5668148A (en) * | 1995-04-20 | 1997-09-16 | Merck & Co., Inc. | Alpha1a adrenergic receptor antagonists |
| DE19517056A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-5,6,7,8-tetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517025A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | Trifluortetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517060A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517038A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1,8-Difluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517051A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-6,7-dihydro-5H-isochinolin-8-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| TW357143B (en) | 1995-07-07 | 1999-05-01 | Novartis Ag | Benzo[g]quinoline derivatives |
| US5849759A (en) | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
| ZA969622B (en) * | 1995-12-13 | 1998-05-15 | Upjohn Co | Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring. |
| JP4169368B2 (ja) | 1996-01-15 | 2008-10-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 脈管形成阻害性ピリダジンアミン |
| EP0880501A1 (en) | 1996-02-02 | 1998-12-02 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| DE19614204A1 (de) | 1996-04-10 | 1997-10-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| GB9614238D0 (en) | 1996-07-06 | 1996-09-04 | Zeneca Ltd | Chemical compounds |
| DE19630068A1 (de) | 1996-07-25 | 1998-01-29 | Basf Ag | Neue flüssigkristalline Verbindungen und deren Vorprodukte |
| WO1998014450A1 (en) | 1996-10-02 | 1998-04-09 | Novartis Ag | Pyrimidine derivatives and processes for the preparation thereof |
| DE59707681D1 (de) * | 1996-10-28 | 2002-08-14 | Rolic Ag Zug | Vernetzbare, photoaktive Silanderivate |
| ZA98376B (en) | 1997-01-23 | 1998-07-23 | Hoffmann La Roche | Sulfamide-metalloprotease inhibitors |
| AU8096798A (en) | 1997-06-27 | 1999-01-19 | Resolution Pharmaceuticals Inc. | Dopamine d4 receptor ligands |
| KR20000068568A (ko) | 1997-07-17 | 2000-11-25 | 이데이 노부유끼 | 자기기록매체 및 이것을 이용한 자기기록 재생장치 |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| SE9703377D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| AR013693A1 (es) | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria |
| ATE278670T1 (de) | 1997-10-27 | 2004-10-15 | Neurosearch As | Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren |
| AU1692399A (en) | 1997-12-26 | 1999-07-19 | Mochida Pharmaceutical Co., Ltd. | Aromatic compounds having cyclic amino or salts thereof |
| ES2182485T3 (es) | 1998-02-13 | 2003-03-01 | Upjohn Co | Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos. |
| JP2002504550A (ja) | 1998-02-25 | 2002-02-12 | ファルマシア・アンド・アップジョン・カンパニー | 抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体 |
| DK1064273T3 (da) | 1998-03-19 | 2003-03-31 | Upjohn Co | 1,3,4-Thiadiazoler, som er nyttige til behandling af CMV-infektioner |
| DE59914996D1 (en) * | 1998-04-20 | 2009-05-14 | Abbott Gmbh & Co Kg | Heterocyclisch substituierte amide als calpainhemmer |
| CN1111523C (zh) | 1998-04-29 | 2003-06-18 | 阿克西瓦有限公司 | 催化制备取代的联吡啶衍生物的方法 |
| KR100579792B1 (ko) | 1998-05-13 | 2006-05-12 | 동화약품공업주식회사 | 신규 2,5-피리딘디카복실산 유도체 |
| GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
| IL140084A0 (en) | 1998-06-05 | 2002-02-10 | Astra Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| DE69919361T2 (de) * | 1998-08-25 | 2005-09-08 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung |
| CA2346396C (en) | 1998-10-09 | 2009-04-28 | Janssen Pharmaceutica N.V. | 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| EP1123936B1 (en) * | 1998-10-21 | 2003-12-10 | Takeda Chemical Industries, Ltd. | Fused pyridazine derivatives, process for the preparation of the same and uses thereof |
| WO2000025768A1 (en) | 1998-10-29 | 2000-05-11 | Trega Biosciences, Inc. | Oxadiazole, thiadiazole and triazole derivatives and combinatorial libraries thereof |
| WO2000032193A1 (en) | 1998-12-02 | 2000-06-08 | Novo Nordisk A/S | Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis |
| GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
| WO2000044743A1 (en) | 1999-01-28 | 2000-08-03 | Nippon Shinyaku Co., Ltd. | Amide derivatives and drug compositions |
| NZ512884A (en) | 1999-01-29 | 2004-03-26 | Abbott Lab | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| DK1035115T3 (da) | 1999-02-24 | 2005-01-24 | Hoffmann La Roche | 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister |
| ID30176A (id) | 1999-03-12 | 2001-11-08 | Boehringer Ingelheim Pharma | Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi |
| AU766081B2 (en) | 1999-03-30 | 2003-10-09 | Novartis Ag | Phthalazine derivatives for treating inflammatory diseases |
| AU779550B2 (en) | 1999-04-09 | 2005-01-27 | Meiji Seika Kaisha Ltd. | Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| FR2792314B1 (fr) * | 1999-04-15 | 2001-06-01 | Adir | Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2000066578A1 (en) | 1999-04-30 | 2000-11-09 | Pfizer Products Inc. | Compounds for the treatment of obesity |
| DE19922723A1 (de) | 1999-05-18 | 2000-11-23 | Clariant Gmbh | Aktivmatrix-Displays mit hohem Kontrast |
| AU5020400A (en) | 1999-05-20 | 2000-12-12 | E.I. Du Pont De Nemours And Company | Heteroaryloxypyrimidine insecticides and acaricides |
| GB9912413D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| AU6000900A (en) | 1999-07-23 | 2001-02-13 | Astrazeneca Uk Limited | Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| DE19934799B4 (de) | 1999-07-28 | 2008-01-24 | Az Electronic Materials (Germany) Gmbh | Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten |
| US6114365A (en) * | 1999-08-12 | 2000-09-05 | Pharmacia & Upjohn S.P.A. | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| US6127382A (en) * | 1999-08-16 | 2000-10-03 | Allergan Sales, Inc. | Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| ES2307528T3 (es) | 1999-09-04 | 2008-12-01 | Astrazeneca Ab | Amidas como inhibidores para la piruvato deshidrogenasa. |
| US6156758A (en) | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
| AUPQ288499A0 (en) | 1999-09-16 | 1999-10-07 | Biota Scientific Management Pty Ltd | Antiviral agents |
| CA2385589A1 (en) | 1999-09-17 | 2001-03-22 | Bing-Yan Zhu | Inhibitors of factor xa |
| SI1225874T1 (sl) | 1999-09-24 | 2006-06-30 | Janssen Pharmaceutica Nv | Protivirusne trdne disperzije |
| US6677452B1 (en) * | 1999-09-30 | 2004-01-13 | Lion Bioscience Ag | Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof |
| EP1226123A1 (en) | 1999-11-03 | 2002-07-31 | Du Pont Pharmaceuticals Company | Cyano compounds as factor xa inhibitors |
| EP1243268A4 (en) | 1999-12-14 | 2003-05-21 | Nippon Shinyaku Co Ltd | MEDICINAL COMPOSITION |
| SE9904652D0 (sv) | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| JP2003519143A (ja) | 1999-12-28 | 2003-06-17 | ファーマコピーア,インコーポレーティッド | ピリミジン及びトリアジン系キナーゼ阻害剤 |
| AU2001243158A1 (en) | 2000-02-18 | 2001-08-27 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| AU2001238424A1 (en) | 2000-02-18 | 2001-08-27 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| AU4722801A (en) * | 2000-02-24 | 2001-09-03 | Xenon Genetics Inc | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| EP1261327B1 (en) | 2000-02-25 | 2005-04-27 | F.Hoffmann-La Roche Ag | Adenosine receptor modulators |
| US6605615B2 (en) | 2000-03-01 | 2003-08-12 | Tularik Inc. | Hydrazones and analogs as cholesterol lowering agents |
| MXPA02008103A (es) | 2000-03-15 | 2002-11-29 | Warner Lambert Co | Diarilaminas sustituidas con 5-amida como inhibidores mek. |
| EP1339702A1 (en) | 2000-03-15 | 2003-09-03 | Warner-Lambert Company | 5-amide substituted diarylamines as mek inhibitors |
| US6613917B1 (en) | 2000-03-23 | 2003-09-02 | Allergan, Inc. | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| CN1440383A (zh) | 2000-04-28 | 2003-09-03 | 三共株式会社 | PPARγ调制剂 |
| CN1657523A (zh) * | 2000-04-28 | 2005-08-24 | 田边制药株式会社 | 环状化合物 |
| GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
| GB0013383D0 (en) | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
| GB0013378D0 (en) | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Use of therapeutic benzamide derivatives |
| GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| KR20030024799A (ko) | 2000-07-20 | 2003-03-26 | 뉴로젠 코포레이션 | 캡사이신 수용체 리간드 |
| DE60130771T2 (de) * | 2000-07-27 | 2008-07-17 | Eli Lilly And Co., Indianapolis | Substituierte heterocyclische amide |
| AU2001282267A1 (en) * | 2000-08-08 | 2002-02-18 | Sanofi-Aventis | Benzimidazole derivatives, preparation and therapeutic use thereof |
| MXPA03001306A (es) * | 2000-08-11 | 2003-10-15 | Boehringer Ingelheim Pharma | Compuestos heterociclicos utiles como inhibidores de las quinasas de tirosina. |
| EP1184442A1 (en) | 2000-08-30 | 2002-03-06 | Clariant International Ltd. | Liquid crystal mixture |
| DE60134995D1 (de) | 2000-09-26 | 2008-09-04 | Xenon Pharmaceuticals Inc | Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden |
| FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| MXPA03003264A (es) | 2000-10-13 | 2003-06-06 | Neurosearch As | Tratamiento de trastornos afectivos mediante la accion combinada de un agonista del receptor nicotinico y una sustancia monoaminergica. |
| EP1328509B1 (en) | 2000-10-17 | 2006-03-22 | Pharmacia & Upjohn Company LLC | Methods of producing oxazolidinone compounds |
| DE10060412A1 (de) * | 2000-12-05 | 2002-06-06 | Bayer Ag | DELTA1-Pyrroline |
| US7129242B2 (en) | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
| DE60117605T2 (de) * | 2000-12-21 | 2006-12-07 | Bristol-Myers Squibb Co. | Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie |
| JP2004520347A (ja) | 2001-01-15 | 2004-07-08 | グラクソ グループ リミテッド | Ldl−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体 |
| WO2002055013A2 (en) | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chromone compounds |
| WO2002055014A2 (en) | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chroman compounds |
| IL156595A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| ATE412638T1 (de) | 2001-02-16 | 2008-11-15 | Aventis Pharma Inc | Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden |
| US7126003B2 (en) | 2001-03-07 | 2006-10-24 | Daiichi Pharmaceutical Co., Ltd. | Method for producing 2-azetidinone derivative |
| US20020169166A1 (en) | 2001-03-09 | 2002-11-14 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| US6803362B2 (en) | 2001-03-09 | 2004-10-12 | Ortho-Mcneil Pharmaceutical Inc. | Heterocyclic compounds |
| US20040147573A1 (en) * | 2001-03-15 | 2004-07-29 | Anders Eriksson | Metalloproteinase inhibitors |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| DK1373218T3 (da) | 2001-03-29 | 2008-05-19 | Ortho Mcneil Pharm Inc | Imidazolylderivater til anvendelse som histamin H3-receptorligander |
| FR2823209B1 (fr) * | 2001-04-04 | 2003-12-12 | Fournier Lab Sa | Nouvelles thiohydantoines et leur utilisation en therapeutique |
| US20040106794A1 (en) | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| PT1818325E (pt) | 2001-04-16 | 2010-05-12 | Schering Corp | Ciclobuteno-1,2-dionas 3,4-di-substituídas como ligandos de receptor de quimoquina cxc |
| US6911447B2 (en) * | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| CN1522251A (zh) | 2001-05-09 | 2004-08-18 | ס������ũҩ��ʽ���� | 唑化合物及其制备方法和应用 |
| AU2002310187A1 (en) | 2001-05-30 | 2002-12-09 | Lg Biomedical Institute | Inhibitors of protein kinase for the treatment of disease |
| WO2002102778A1 (en) | 2001-06-15 | 2002-12-27 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylpyridine carbonyl piperazine derivative |
| WO2003003008A1 (en) | 2001-06-29 | 2003-01-09 | 7Tm Pharma A/S | Chemical libraries useful for drug discovery processes |
| WO2003004488A1 (en) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| US7115607B2 (en) * | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| EP1417188A1 (en) | 2001-08-03 | 2004-05-12 | Novo Nordisk A/S | Novel 2,4-diaminothiazole derivatives |
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| AU2002323475B2 (en) | 2001-09-13 | 2006-09-28 | Synta Pharmaceuticals Corp | 2-aroylimidazole compounds for treating cancer |
| FR2829926B1 (fr) * | 2001-09-26 | 2004-10-01 | Oreal | Composition pour la teinture des fibres keratiniques comprenant un colorant diazoique dicationique particulier |
| US6916812B2 (en) * | 2001-10-09 | 2005-07-12 | Bristol-Myers Squibb Company | Alpha-aminoamide derivatives as melanocortin agonists |
| US6824707B2 (en) * | 2001-10-23 | 2004-11-30 | Clariant International Ltd. | Active matrix liquid crystal device and smectic liquid crystal mixture |
| WO2003035602A1 (en) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Lipid modulators |
| US20050014942A1 (en) * | 2001-10-30 | 2005-01-20 | Yasufumi Maruyama | Amide derivatives and drugs |
| SE0103649D0 (sv) | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| SE0103648D0 (sv) | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| GB0127008D0 (en) | 2001-11-09 | 2002-01-02 | Novartis Ag | Organic compounds |
| US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| EP1451156A4 (en) | 2001-11-27 | 2005-05-25 | Merck & Co Inc | 4-AMINOCHINOLINVERBINDUNGEN |
| AU2002344567A1 (en) | 2001-11-28 | 2003-06-10 | Daiso Co., Ltd. | Heterocyclic amide compounds as apolipoprotein b inhibitors |
| EP1452530A4 (en) | 2001-12-03 | 2005-11-30 | Japan Tobacco Inc | AZOL CONNECTION AND THEIR MEDICAL USE |
| FR2833261B1 (fr) * | 2001-12-06 | 2004-07-02 | Yang Ji Chemical Company Ltd | Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii |
| US7449457B2 (en) | 2001-12-07 | 2008-11-11 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
| US6806279B2 (en) | 2001-12-17 | 2004-10-19 | Sunesis Pharmaceuticals, Inc. | Small-molecule inhibitors of interleukin-2 |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US7390813B1 (en) * | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
| US20030166932A1 (en) * | 2002-01-04 | 2003-09-04 | Beard Richard L. | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| AU2003203148A1 (en) | 2002-02-05 | 2003-09-02 | High Point Pharmaceuticals, Llc | Novel aryl- and heteroarylpiperazines |
| EP1485348B1 (en) | 2002-03-13 | 2008-06-11 | Janssen Pharmaceutica N.V. | Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| US7501417B2 (en) | 2002-03-13 | 2009-03-10 | Janssen Pharmaceutica, N.V. | Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| OA12793A (en) | 2002-03-13 | 2006-07-10 | Janssen Pharmaceutica Nv | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase. |
| ATE395343T1 (de) | 2002-03-13 | 2008-05-15 | Janssen Pharmaceutica Nv | Sulfonylderivate als histone-deacetylase- inhibitoren |
| AR038966A1 (es) | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1 |
| WO2003080060A1 (en) | 2002-03-20 | 2003-10-02 | Schering Aktiengesellschaft | Substituted piperazine antithrombotic pai-1 inhibitors |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| AU2003221786A1 (en) | 2002-04-25 | 2003-11-10 | Pharmacia Corporation | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| GB0209715D0 (en) | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| US6637592B1 (en) * | 2002-04-30 | 2003-10-28 | Eagle Tool Co., Ltd. | Tool case |
| US6982259B2 (en) | 2002-04-30 | 2006-01-03 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
| JP2005289816A (ja) * | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| HUP0202001A2 (hu) | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
| AU2003249369A1 (en) | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain amino-substituted monocycles as kinase modulators |
| AU2003245669A1 (en) | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain aromatic monocycles as kinase modulators |
| JP3854204B2 (ja) * | 2002-07-22 | 2006-12-06 | アルプス電気株式会社 | 薄膜磁気ヘッド |
| WO2004009587A1 (en) | 2002-07-22 | 2004-01-29 | Orchid Chemicals & Pharmaceuticals Ltd | Oxazolidinone derivatives as antibacterial agents |
| JPWO2004011430A1 (ja) | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
| CA2493584A1 (en) | 2002-07-25 | 2004-02-05 | Wisconsin Alumni Research Foundation | Inhibition of stearoyl-coa desaturase 1 (scd1) increases insulin sensitivity and treats diabetes |
| US7144888B2 (en) | 2002-08-08 | 2006-12-05 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| ATE364608T1 (de) | 2002-09-04 | 2007-07-15 | Schering Corp | Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen |
| CA2497829A1 (en) | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Method to treat allergic rhinitis |
| WO2004026863A1 (en) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| AP2005003262A0 (en) | 2002-09-18 | 2005-03-31 | Pfizer Prod Inc | Novel isothiazole and isoxazole compounds as tranforming growth factor (TGF) inhibitors. |
| JP2006505570A (ja) | 2002-10-17 | 2006-02-16 | アムジエン・インコーポレーテツド | ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用 |
| GB0224919D0 (en) | 2002-10-25 | 2002-12-04 | Pfizer Ltd | Triazole compounds useful in therapy |
| DE10250708A1 (de) | 2002-10-31 | 2004-05-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| FR2847253B1 (fr) | 2002-11-19 | 2007-05-18 | Aventis Pharma Sa | Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant |
| DE10254875A1 (de) | 2002-11-25 | 2004-06-03 | Bayer Healthcare Ag | Phenylsulfoxid und -sulfon-Derivate |
| JP2004203871A (ja) | 2002-12-13 | 2004-07-22 | Yamanouchi Pharmaceut Co Ltd | 医薬組成物 |
| DE10259382A1 (de) | 2002-12-18 | 2004-07-01 | Abbott Gmbh & Co. Kg | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung |
| WO2004058727A1 (en) | 2002-12-20 | 2004-07-15 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| EP1599468B1 (en) | 2003-01-14 | 2007-10-03 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| JP2006516561A (ja) | 2003-01-17 | 2006-07-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 細胞増殖の阻害剤としての2−アミノピリジン置換ヘテロ環類 |
| US20050130989A1 (en) * | 2003-01-28 | 2005-06-16 | Aventis Pharma S. A. | N-arylheteroaromatic products compositions containing them and use thereof |
| EP2308848A1 (en) | 2003-02-03 | 2011-04-13 | Janssen Pharmaceutica NV | Quinoline-derived amide modulators of vanilloid VR1 receptor |
| GB0302671D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| US20070021449A1 (en) | 2003-02-07 | 2007-01-25 | Jan Heeres | Pyrimidine derivatives for the prevention of hiv infection |
| KR20050105190A (ko) | 2003-02-07 | 2005-11-03 | 얀센 파마슈티카 엔.브이. | Hiv를 저해하는 1,2,4-트리아진 |
| US7223788B2 (en) * | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| CN1753873A (zh) | 2003-02-22 | 2006-03-29 | 默克专利股份有限公司 | 作为液晶的氰基吡啶酮衍生物 |
| DE602004017703D1 (de) | 2003-02-24 | 2008-12-24 | Arena Pharm Inc | Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus |
| US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| WO2004078717A1 (en) | 2003-03-03 | 2004-09-16 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| JP2006522750A (ja) | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法 |
| CA2523831C (en) | 2003-04-29 | 2008-11-18 | Pfizer Inc. | 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension |
| MXPA05012281A (es) | 2003-05-14 | 2006-05-19 | Torreypines Therapeutics Inc | Compuestos y uso de los mismos en la modulacion beta amiloide. |
| DE10322408A1 (de) | 2003-05-16 | 2004-12-02 | Degussa Ag | Stickstoffhaltige monodentate Phosphine und deren Verwendung in der Katalyse |
| PE20050226A1 (es) | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
| GB0312832D0 (en) | 2003-06-04 | 2003-07-09 | Pfizer Ltd | 2-amino-pyridine derivatives useful for the treatment of diseases |
| SE0301886D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use V |
| CA2529790A1 (en) | 2003-06-27 | 2005-01-27 | Banyu Pharmaceutical Co., Ltd. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| WO2005003087A2 (en) | 2003-07-01 | 2005-01-13 | Orchid Chemicals And Pharmaceuticals Ltd. | Oxazole derivatives as antibacterial agents |
| BRPI0412596A (pt) | 2003-07-16 | 2006-09-19 | Janssen Pharmaceutica Nv | derivados de triazolopirimidina como inibores de glicogênio sintase cinase 3 |
| US7449465B2 (en) | 2003-07-16 | 2008-11-11 | Janssen Pharmaceutica, N.V. | Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| JP2006528640A (ja) | 2003-07-22 | 2006-12-21 | ニューロジェン・コーポレーション | 置換ピリジン−2−イルアミン類縁体 |
| FR2857966A1 (fr) * | 2003-07-24 | 2005-01-28 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| AR045134A1 (es) | 2003-07-29 | 2005-10-19 | Smithkline Beecham Plc | Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic |
| KR20060036105A (ko) | 2003-07-29 | 2006-04-27 | 제논 파마슈티칼스 인크. | 피리딜 유도체 및 그의 치료제로서의 용도 |
| DK1651615T3 (da) * | 2003-07-29 | 2010-05-25 | High Point Pharmaceuticals Llc | Pyridazinyl-piperaziner og anvendelse deraf som histamin-H3-receptorligander |
| US7754711B2 (en) * | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| BRPI0412348A (pt) | 2003-07-30 | 2006-09-05 | Xenon Pharmaceuticals Inc | derivados de piperazina e seu uso como agentes terapêuticos |
| ES2386353T3 (es) | 2003-07-30 | 2012-08-17 | Xenon Pharmaceuticals Inc. | Derivados de piridazina y su uso como agentes terapéuticos |
| TWI345974B (en) * | 2003-07-30 | 2011-08-01 | Xenon Pharmaceuticals Inc | Pyridazine derivatives and their use in the inhibition of stearoyl-coa desaturase |
| CA2533900A1 (en) | 2003-07-30 | 2005-02-10 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| WO2005014563A1 (en) * | 2003-08-11 | 2005-02-17 | F. Hoffmann-La Roche Ag | Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| EP2426120A1 (en) | 2003-08-18 | 2012-03-07 | Fujifilm Finechemicals Co., Ltd. | Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them |
| WO2005021548A2 (en) | 2003-08-25 | 2005-03-10 | Adenosine Therapeutics, Llc | Substituted 8-heteroaryl xanthines |
| JPWO2005021550A1 (ja) * | 2003-08-29 | 2006-10-26 | 大日本住友製薬株式会社 | 二環性ピラゾール誘導体 |
| EP1663232B1 (en) | 2003-09-09 | 2007-10-03 | F. Hoffmann-La Roche Ag | 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| RU2355683C2 (ru) | 2003-09-09 | 2009-05-20 | Ф.Хоффманн-Ля Рош Аг | Производные 1-бензоилпиперазина в качестве ингибиторов поглощения глицина для лечения психозов |
| US20050065178A1 (en) | 2003-09-19 | 2005-03-24 | Anwer Basha | Substituted diazabicycloakane derivatives |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| DE602004031641D1 (de) | 2003-09-25 | 2011-04-14 | Janssen Pharmaceutica Nv | Die replikation von hiv hemmende purinderivate |
| ES2651730T3 (es) | 2003-09-26 | 2018-01-29 | Exelixis, Inc. | Moduladores c-Met y métodos de uso |
| UY28538A1 (es) | 2003-09-26 | 2005-04-29 | Vertex Pharma | Derivados de fenil-piperazina como moduladores de receptores muscarínicos |
| US7199149B2 (en) | 2003-10-01 | 2007-04-03 | Bristol Myers Squibb Company | Monocyclic and bicyclic lactams as factor Xa inhibitors |
| US7807696B2 (en) | 2003-10-07 | 2010-10-05 | The Feinstein Institute For Medical Research | Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| FR2860793A1 (fr) | 2003-10-14 | 2005-04-15 | Entomed | Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations |
| US20050124625A1 (en) | 2003-10-21 | 2005-06-09 | Salvati Mark E. | Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| US20050192286A1 (en) | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
| BRPI0415851A (pt) | 2003-10-24 | 2007-01-02 | Solvay Pharm Gmbh | utilizações médicas de compostos que apresentam atividade antagonìstica de cb1 e tratamento de combinação envolvendo os referidos compostos |
| US20050124660A1 (en) * | 2003-10-27 | 2005-06-09 | Jochen Antel | Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| EP1680114A4 (en) | 2003-10-28 | 2008-09-24 | Amgen Inc | TRIAZOL COMPOUNDS AND RELEVANT PROCEDURES |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| GB0327323D0 (en) | 2003-11-24 | 2003-12-31 | Pfizer Ltd | Novel pharmaceuticals |
| GB0327319D0 (en) | 2003-11-24 | 2003-12-24 | Pfizer Ltd | Novel pharmaceuticals |
| JP4740151B2 (ja) | 2003-12-18 | 2011-08-03 | インサイト コーポレイション | ケモカイン受容体のモジュレーターとしての3‐シクロアルキルアミノピロリジン誘導体 |
| CA2551038C (en) | 2003-12-22 | 2010-04-27 | Pfizer Inc. | Triazole derivatives as vasopressin antagonists |
| US7345043B2 (en) * | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| AR048523A1 (es) | 2004-04-07 | 2006-05-03 | Kalypsys Inc | Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos |
| FR2868780B1 (fr) * | 2004-04-13 | 2008-10-17 | Sanofi Synthelabo | Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique |
| JP2008503469A (ja) | 2004-06-17 | 2008-02-07 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニスト |
| AU2004321997A1 (en) | 2004-07-06 | 2006-02-09 | Xenon Pharmaceuticals Inc. | Nicotinamide derivatives and their use as therapeutic agents |
| AU2005287170B2 (en) | 2004-09-17 | 2012-03-29 | Exelixis, Inc | Pyrazole kinase modulators and methods of use |
| WO2006034441A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| AU2005286790A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD) |
| JP4958785B2 (ja) | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体およびステアロイル−CoAデサチュラーゼインヒビターとしてのそれらの使用 |
| TW200626155A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| ES2359840T5 (es) | 2004-09-20 | 2015-03-25 | Xenon Pharmaceuticals Inc. | Derivados de piridina para inhibición de estearoil-CoA-desaturasa humana |
| CN101084211A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
| AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| BRPI0519794A2 (pt) | 2005-01-07 | 2009-03-17 | Hoffmann La Roche | derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos |
| WO2006106423A2 (en) | 2005-04-07 | 2006-10-12 | Pfizer Inc. | Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| US20090099200A1 (en) | 2005-06-09 | 2009-04-16 | Chun Sing Li | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| WO2008123891A1 (en) * | 2007-04-09 | 2008-10-16 | Cv Therapeutics, Inc. | PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
-
2006
- 2006-06-05 WO PCT/US2006/021660 patent/WO2007130075A1/en not_active Ceased
- 2006-06-05 MX MX2007015216A patent/MX2007015216A/es unknown
- 2006-06-05 BR BRPI0611187-4A patent/BRPI0611187A2/pt not_active IP Right Cessation
- 2006-06-05 CN CNA200680019628XA patent/CN101208089A/zh active Pending
- 2006-06-05 JP JP2008525998A patent/JP2009513563A/ja active Pending
- 2006-06-05 US US11/916,243 patent/US8541457B2/en not_active Expired - Fee Related
- 2006-06-05 AU AU2006343359A patent/AU2006343359A1/en not_active Abandoned
- 2006-06-05 EP EP12005821A patent/EP2540296A1/en not_active Withdrawn
- 2006-06-05 EP EP06784578A patent/EP2029138A1/en not_active Withdrawn
- 2006-06-05 CA CA002618646A patent/CA2618646A1/en not_active Abandoned
-
2012
- 2012-09-14 US US13/620,339 patent/US20130096056A1/en not_active Abandoned
-
2013
- 2013-03-05 JP JP2013042546A patent/JP2013100376A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009513563A5 (enExample) | ||
| RU2461551C2 (ru) | Азолкарбоксамидное соединение или его фармацевтически приемлемая соль | |
| JP5261383B2 (ja) | ヒトプロテインチロシンホスファターゼ阻害剤および使用法 | |
| US8541457B2 (en) | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors | |
| KR101155365B1 (ko) | 인간 단백질 타이로신 포스파타아제 억제제 및 사용 방법 | |
| JP2010519181A5 (enExample) | ||
| RU2013120064A (ru) | Композиции и способы лечения глазного отека, неоваскуляризации и связанных с ними заболеваний | |
| HRP20110825T1 (hr) | Derivati aminotriazola kao alx agonisti | |
| EP2041129A2 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
| RU2011133833A (ru) | Способы лечения синдрома сосудистой утечки | |
| JP2009524677A5 (enExample) | ||
| JP2006077019A5 (enExample) | ||
| RU2004122407A (ru) | Амидные производные в качестве активаторов gk | |
| RU2008151051A (ru) | Органические соединения | |
| RU2011153772A (ru) | Фторированные аминотриазольные производные | |
| RU2009108275A (ru) | Соединение сульфонамида или его соль | |
| JP2005514432A5 (enExample) | ||
| RU2004129285A (ru) | Производные тиазола в качестве антагонистов рецептора npy | |
| RU2015126293A (ru) | Производные тиазола в качестве ингибиторов тирозинкиназы брутона | |
| CN101506180B (zh) | 人蛋白酪氨酸磷酸酶抑制剂及使用方法 | |
| JP2007538102A5 (enExample) | ||
| RU2435763C2 (ru) | Ингибиторы тирозинфосфатазы белка человека и способы применения | |
| RU2471796C2 (ru) | Соединения 3-аза-бицикло[3.3.0]октана |